Alterations of CCSP expression and macrophages metabolism in the development of silica-induced pulmonary inflammation and fibrosis by Marrocco, Antonella
   
Title Page 
Alterations of CCSP Expression and Macrophages Metabolism in the Development of 
Silica-Induced Pulmonary Inflammation and Fibrosis 
 
 
 
 
 
 
 
 
 
by 
 
Antonella Marrocco 
 
Laurea Specialistica in Medicina e chirurgia, Seconda Università degli studi di Napoli, Italy, 2008 
 
Diploma di Specializzazione in Medicina del Lavoro, Seconda Università degli studi di Napoli, Italy, 2015 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of the 
 
Department of Environmental and Occupational Health 
 
Graduate School of Public Health in partial fulfillment 
  
of the requirements for the degree of 
 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
2020
 ii 
Committee Page 
UNIVERSITY OF PITTSBURGH 
 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Antonella Marrocco 
 
 
It was defended on 
 
June 5, 2020 
 
and approved by 
 
Linda L. Pearce, PhD, Assistant Professor, Department of Environmental and Occupational 
Health, Graduate School of Public Health, University of Pittsburgh 
 
James Peterson, PhD, Associate Professor, Department of Environmental and Occupational 
Health, Graduate School of Public Health, University of Pittsburgh 
 
Stacy L. Wendell, PhD, Assistant Professor, Department of Pharmacology & Chemical Biology 
Director, Health Sciences Metabolomics and Lipidomics Core, School of Medicine, University 
of Pittsburgh 
 
Bruce Pitt, PhD, Professor, Department of Environmental and Occupational Health, Graduate 
School of Public Health, University of Pittsburgh 
 
Dissertation Director: Luis A. Ortiz, MD, Professor, Department of Environmental and 
Occupational Health, Graduate School of Public Health, University of Pittsburgh 
  
 iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © by Antonella Marrocco 
 
2020 
 
 
 
 
 iv 
Abstract 
Alterations of CCSP Expression and Macrophages Metabolism in the Development of 
Silica-Induced Pulmonary Inflammation and Fibrosis 
 
Antonella Marrocco, PhD 
 
University of Pittsburgh, 2020 
 
Abstract 
 
Silicosis is a lethal pneumoconiosis, for which no therapy is available. Silicosis is a public 
health threat: more than 2.2 million people/year in the US and 230 million/year worldwide, are 
exposed to silica, and consequently are at increased risk of active mycobacterial tuberculosis (TB), 
and lung cancer. The initial response to silica is mediated by the innate immunity in a two-stage 
process: 1)injury of conducting epithelium at distal lung, loss of Club cells secretory protein 
(CCSP), and impairment of regenerative capacity; 2)phagocytosis of silica by macrophages, 
metabolic alterations, oxidative stress, and release of reactive-oxygen-species (ROS) and 
inflammatory cytokines, such as Interleukin-(IL-)1β, Tumor necrosis factor-(TNF-)α, Interferon-
(IFN-)β. However, the specific role of airway epithelium and macrophage in the pathogenesis of 
silicosis in humans is poorly understood. 
This study focuses on whether silica-induced inflammation compromises the Club cells 
ability to regenerate bronchiolar and/or alveolar epithelium and on the macrophages metabolic 
alterations that occurs upon phagocytosis of silica, leading to chronic inflammation.  
Using wild-type and CCSP-deficient (CCSP-/-) mice we exhibit that the development of 
the silicotic nodules in the lung is characterized by peri-bronchiolar inflammatory cell recruitment 
and tissue fibrosis, that compromises the expression and proliferation of CCSP-expressing 
progenitor cells and limits the reparative properties of the distal airway epithelium, resulting in 
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exacerbation of silicosis. We reveal an immunomodulatory role for CCSP in response to silica 
both in mice and in human lungs.  
Subsequently, using murine RAW 264.7 macrophage cell lines, and state- of- art techniques, 
such as high-resolution respirometer and liquid chromatography-high resolution mass 
spectrometry (LC-HRMS), to determine the effects of silica on mitochondrial respiration, and the 
changes in central carbon metabolism of silica-exposed macrophages, we demonstrate that in 
contrast to the prevalent view, crystalline silica alone induces an innate immune response without 
previous macrophage activation with LPS, and yet different from the one LPS-induced, since they 
affect differently the CII of ETC, which plays a crucial role in macrophages survival and silica-
induced inflammation. 
Our data highlight the urgency to validate these concepts and elucidate the mechanisms 
underlying the silica-induced impairment of macrophages, development of inflammation and 
fibrosis, and consequent increased TB risk. 
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1.0 Introduction 
1.1 Crystalline silica occupational exposure 
Crystalline silica, also known as silicon dioxide (SiO2), is one of the most abundant 
minerals on Earth. It is an essential component of soil, sand, granite, and many other minerals. The 
most common form of crystalline silica is quartz; two other forms are cristobalite and tridymite. 
All three forms may become respirable size particles (silica <10 μm in diameter) when workers 
chip, cut, drill, or grind objects that contain crystalline silica [1].  
More than 2 million workers in the United States and more than 230 million around the 
world are exposed to silica every year [2-4]. Occupational exposure has been historically 
associated with work in mining, construction, sandblasting, masonry, foundry operations, glass 
manufacturing, ceramic and pottery production, and cement and concrete production and with 
work with specific materials in dental laboratories. However, newly emerging occupations and 
tasks are increasing the risk of exposure: including fabricating and installing quartz-containing 
engineered stone products and extraction of natural gas by hydraulic fracturing [3, 5-9] 
Inhalation of crystalline silica leads to the development of silicosis, a progressive 
pneumoconiosis characterized by lung inflammation and fibrosis, for which no specific therapy is 
available. Silicosis is associated with increased risk of tuberculosis, lung cancer, chronic 
obstructive pulmonary disease (COPD), kidney disease, and autoimmune disease, with these risks 
remaining high even when exposure to silica dust has ceased [3, 10, 11].  
Silica-related diseases are preventable by avoiding or reducing the exposure to silica dust 
in the workplace, implementing the ventilation system, the use of wet methods, and the use of 
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personal protective equipment. Although preventive measures have decreased the mortality 
attributable to silica exposure in the past decade, this occupational lung disease still kills about 100 
people every year in the United States, according to the National Institute for Occupational Safety 
and Health (NIOSH). Between 1999 and 2013, silicosis was the underlying or contributing cause 
of death for about 2000 people, and 300 deaths occurred each year between 1991 and 1995, while 
it decreased to about 100 per year in 2012 and 2013 [5]. Data from NIOSH show that a large 
number of workers are at increased risk for silicosis because the levels of exposure to silica exceed 
the current regulatory standards. Therefore, regulatory agencies have been forced to further reduce 
the permissible exposure levels (PEL) to 25 µg/m3 (micrograms of silica per cubic meter of air) 
over an 8-hour shift, to improve prophylaxis. Despite these efforts, silicosis remains a global health 
threat.  
1.2 Crystalline silica health effects 
Silica exposure has been associated with several disorders. Silicosis is the direct 
consequence of silica exposure, and it is one of the most common occupational lung diseases 
worldwide [12]. Pathological varieties include simple (nodular) silicosis, progressive massive 
fibrosis, silico-proteinosis, and diffuse interstitial fibrosis [3]. 
Increased risk of tuberculosis (TB) has been reported among exposed miners and stone 
crushers [4, 13, 14]. In agreement, nowadays, it has been estimated that silicosis increases the risk 
of active TB by up to four-fold, and exposure to silica dust of healthy or paucisymptomatic 
individuals also has been demonstrated to increase the life-long risk for TB [15]. Reducing 
exposures to silica decreases the likelihood of developing silicosis, and subsequently, tuberculosis. 
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Chronic obstructive pulmonary disease (COPD) has also been associated with silica 
exposure, independent of smoking. In 1997, the International Agency for Research on Cancer 
(IARC) and subsequently NIOSH and the National Toxicology Program (NTP) classified 
crystalline silica inhaled in the form of quartz or cristobalite from occupational sources as a human 
carcinogen (Group 1), due to the correlation between silica exposure and lung cancer.  
The presence of silicosis increases the risk of other mycobacterial, fungal, and bacterial 
lung infections, as well as renal and autoimmune diseases.  
1.3 Pathogenesis of silicosis 
The understanding of the pathogenesis of silicosis is incomplete, and almost no data exist 
in humans [16, 17]. The initial response to silica in the lung is mediated by the innate immunity, 
and it consists of two stages: disruption of the regenerative program in the conducting epithelium, 
and phagocytosis of silica particles by macrophage [18], followed by the establishment of 
oxidative stress, release of ROS [19-23], and the transcription and release of inflammatory 
cytokines such as interleukin (IL)-1β, tumor necrosis factor (TNF)-α and interferons (IFN) [19, 
20, 23-25]. Therapeutic antagonism of these mediators has been proposed in silicosis [19, 20, 23-
25]. 
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1.4 Silica damages the BADJ and decreases the release of CCSP 
The distal portion of bronchi, the transition from bronchioles to alveolar sacs in the lung, 
is known as the bronchoalveolar duct junction (BADJ). It is lined by different types of cells, 
including Club Cells, which are non-ciliated, non-mucous, secretory cells, that represent a primary 
progenitor cell population for ciliated and secretory epithelial cells in the terminal bronchiole, and 
secrete many essential glycoproteins, lipids, and proteins providing chemical and physical 
protection for both pulmonary surfactant and small airways [26]. Specifically, Club cells are the 
source of the immune-modulatory protein Club Cell Secretory Protein (CCSP, also known as 
uteroglobin/blastokinin, CC16, or SCGB1A1) [27-30]. Club Cells are absent in the proximal 
segment of the bronchioles, while in the BADJ they represent the 11-22% of the entire cell 
population, and the 15-44% of all proliferating cells [26, 31]. Other location of Club Cells in the 
human body consists of the gravid uterus, hence the name uteroglobin for the CCSP, kidneys, and 
prostate [26]. 
The CCSP gene is located on chromosome 11, p12-q13, a region involved in allergy and 
inflammation [32]. Even though the exact role of CCSP is not completely clear, there is evidence 
supporting the protective role of CCSP in the respiratory tract against oxidative stress and 
inflammatory response. CCSP inhibits the activation of phospholipase A2 and modulates the 
production of inflammatory cytokines, including IFN gamma and TNF-α [33]. Lack of CCSP in 
mice induces exaggerated inflammatory response to viral infection [34] and exhibit increased 
expression of TNF-α when compared to CCSP competent mice [35]. 
Club cells are also involved in the biotransformation of many inhaled xenobiotic and toxic 
compounds, including furans, hydrocarbons (including aromatic hydrocarbons), naphthalene and 
its derivatives, tobacco smoke, and many other substances, which are mainly detoxified through 
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cytochrome P-450 [30], in a process that can also generate toxic metabolites and lead to cell 
damage and necrosis [30]. 
The peculiar role of CCSP in the regeneration and protection of the epithelial cells is also 
supported by the evidence that decreased levels of this protein in human serum are associated with 
reduced lung function either in childhood and in adulthood [36]. Moreover, the lack of CCSP 
exacerbates the alveolar cell damage and inflammation induced by cigarette smoke and increases 
the risk of mortality for lung cancer [36]. While patients suffering interstitial lung diseases, such 
as sarcoidosis and idiopathic pulmonary fibrosis (IPF), show an increase of CCSP level in serum 
and bronchoalveolar lavage (BAL) [37-39], workers exposed to silica report decrease serum 
concentration of CCSP protein, without any correlation with the time and dose of exposure [40, 
41], suggesting that the decreased serum levels of CCSP could be used as a sensitive prognostic 
indicator of disease progression. 
 The exact mechanism that leads to the silica-induced decreased serum levels of CCSP is 
still unclear. Silica particles can directly damage the Club cells membrane since they are very 
sensitive to toxic compounds [42], alveolar macrophages can engulf silica particles and release 
dangerous cytotoxins, or silica particle can impair the regenerative program of the progenitor Club 
cells. Thus, the decreased level of CCSP in serum mirrors the silica-induced damage of Club cells 
in the lung [43].  
1.5 Metabolic activation of macrophages  
In 2008, Cassel et al. revealed that the development of silicosis is dependent upon the 
activation of the NLRP3 inflammasome [19]. The inflammasome is a complex of proteins 
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composed of multiple subunits, that once activated and assembled with pro-caspase-1, it prompts 
the activation of caspase-1 and the release of mature IL-1β. This process, however, requires two 
different starting signals; the first one is represented by the interaction of Toll-Like Receptor 
(TLR) 4 and its ligand, the lipopolysaccharide (LPS), which activates the transcription factor NF-
κB, and in turn of inflammatory cytokines precursors pro-IL-1β and pro-IL-18. The second signal 
is represented by phagocytosis of silica into phagolysosomes, damage of mitochondria, ROS 
production, assembly of the NLRP3, activation of caspase-1, and releases of mature IL-1β and IL-
18 [19, 20, 23, 44]. 
However, this mechanism implies that LPS is a determinant factor in the immune response 
because macrophage exposed to silica alone cannot be activated and consequently cannot develop 
inflammation and IL-1β release; in contrast, cells primed with LPS can have an enhanced response 
to silica particles. Moreover, it does not explain the high TNF-α secretion during silicosis. 
Previous studies have shown that LPS-activated bone marrow-derived macrophage 
(BMDM) undergoes the “Warburg effect” or aerobic glycolysis [45]. LPS activation increases the 
rate of glycolysis and decreases mitochondrial respiration, accompanied by a defective 
tricarboxylic acid (TCA) cycle and accumulation of succinate [46]. The latter plays a crucial role 
as proinflammatory signal acting via succinate dehydrogenase (SDH) and Reverse Electron 
Transport (RET) through complex I and is responsible for stabilization of HIF-1α and consequent 
secretion of IL-1β. In contrast, inhibition of glycolysis with 2-deoxyglucose (2DG) downregulates 
HIF-1α protein and consequently blocks the release of LPS-induced IL-1β. [47]  
The remodeling of mitochondrial electron-transport chain (ETC) complexes in 
macrophage are required for optimal responses to bacterial infection. Specifically, viable 
Escherichia coli bacteria encountered by macrophages are engulfed in phagosomes, which become 
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surrounded by mitochondria that are adaptively remodeled in response to infection. The adaptation 
consists of changes in mitochondrial super-complexes in the mitochondrial inner membrane that 
result in diminished complex I (CI) and increased complex II (CII) activities, production of toxic 
products such as reactive oxygen species (ROS), fumarate, itaconic acid and perhaps others that 
are delivered locally at high concentrations. This pathway elicits many antibacterial responses, 
several of which are augmented by this upregulation of CII’s activity [48]. 
More recently, in 2017, a study performed by Saborano et al. indicated metabolic 
reprogramming induced by silica nanoparticles in RAW 264.7 macrophages, which is 
characterized by increased glycolytic activity, altered TCA cycle, reduced ATP generation and 
increased TNF-α production, consistent with a pro-inflammatory phenotype.  
1.6 Scope of dissertation and statement of hypothesis 
The present study aimed to elucidate the two particular aspects of the silica-induced 
inflammation and lung fibrosis mentioned above: to clarify the mechanism by which silica 
damages Club cells and compromise the regenerative properties of stem cells of the distal lung 
epithelium, and to determine the immune-metabolic responses induced by silica in macrophage 
that leads to the secretion of cytokines and perpetuation of inflammation. We hypothesize that 
silica induces macrophage metabolic reprogramming characterized by alteration of glycolysis, and 
mitochondrial respiration, mediated by adaptation of ETC, which is necessary for the cell survival 
through the release of inflammatory cytokines. 
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2.0 Club Cell Secretory Protein (CCSP) Regulates the Innate Immune Response in Silicosis 
2.1 Introduction 
Occupational or environmental exposure to silica is associated with the development of 
silicosis, a lung disease characterized by progressive granulomatous inflammation and pulmonary 
fibrosis, autoimmune disease, mycobacterial infection, and lung cancer [3]. Despite significant 
progress in its prevention, silicosis remains a major global health problem associated with high 
morbidity and mortality for which no specific therapy is available [10, 11]. 
The pathogenesis of silica-induced lung disease is not entirely understood, almost no data 
exist in humans [16, 17], and most of our knowledge focuses on the role that immune cells play in 
this process. Consequently, the current hypothesis indicates that the initial response to silica in the 
lung is mediated by innate immunity. Phagocytosis of silica particles by alveolar macrophages 
[18] is followed by the establishment of oxidative stress, the release of ROS [19-21, 23], activation 
of the NLRP3 inflammasome and the transcription and release of inflammatory cytokines such as 
IL-1β and TNF-α [19, 20, 23-25]. 
However, this hypothesis does not take into account the role that lung epithelium plays in 
the pathogenesis of silicosis and the disruption of the regenerative program in the conducting 
epithelium.  
In transgenic mice expressing an epithelial-restricted IB (nuclear factor kappa-light-
chain-enhancer of activated B cells inhibitor) moiety that cannot be phosphorylated, we previously 
demonstrated a role for the epithelium in that inhibition of the pro-survival NF-B (nuclear factor 
kappa-light-chain-enhancer of activated B cells) in Club cells or type II alveolar epithelial cells is 
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associated with enhanced apoptosis of these cells and significantly worse silica-induced lung 
inflammation and fibrosis [10].  
As mentioned above, the BADJ is lined by different types of cells, including Club cells 
secretory cells that represent an abundant progenitor cell population and the source of the immune-
modulatory protein CCSP [27-29].  
Studies in crystalline silica or asbestos-exposed workers demonstrated that decreased 
serum levels of CCSP could be used as a sensitive prognostic indicator of disease progression [43, 
49]. These studies suggest that the reduced CCSP levels in asymptomatic patients are the result of 
damaged Club cells associated with diminished secretory function regardless of the dose of silica 
exposure [43]. In sharp contrast to silicosis, BAL, and serum concentrations of CCSP were 
markedly increased in IPF, although most of the studied IPF patients were smokers [37]. The serum 
concentration of CCSP is also augmented in other fibrotic lung diseases like hypersensitivity 
pneumonitis and those associated with some connective tissue diseases [37-39]. A significant 
reduction in CCSP levels is identified, as early as three days, after exposures of rats to silica [50]. 
In mice, injuries specifically targeted to stem and transit-amplifying cells of conducting airways 
have a profound impact on alveolar homeostasis, suggesting that crosstalk between bronchiolar 
and alveolar compartments has a critical role in modulating lung function and tissue remodeling 
[51, 52]. Based upon these known functions of Club cells and the changes in CCSP described in 
silica-exposed miners, we hypothesize that silica exposure directly affects the reparative properties 
of the distal airway epithelium leading to Club cell deficiency and associated immunomodulatory 
perturbations that promote macrophage activation and exacerbation of fibrotic remodeling.  
Consistent with an immune-regulatory role for Club cells and CCSP in lung injury, we 
previously reported that exposure of Club cell-depleted or CCSP-deficient (CCSP-/-) mice 
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modulate the in vivo response to LPS by enhancing expression of TLR4 and inducing the 
production of TNF-α by macrophages [53]. TNF-α plays a fundamental role in the pathogenesis 
of silica-induced lung injury and human, as well as mouse lungs exposed to silica, demonstrate 
enhanced macrophage TNF-α production in a manner that precedes the inflammatory response and 
the accumulation of lung collagen [16].  
Despite the ample evidence that the toxic action of silica on the lung structures is closely 
linked to the ability of silica particles to damage cell membranes, the exact molecular process and 
progression are still not wholly understood, and different mechanisms have been proposed. 
Decreased secretion of CCSP by Club cells might be due to direct cell damage by silica, might be 
consecutive to lesions of other cell types within the respiratory epithelium which are sensitive to 
lung irritants, or Club cells are damaged by cytotoxic mediators released from activated 
macrophages that have engulfed silica particles [43].  
The present study was designed to determine whether the altered CCSP expression 
described following silica exposure is the result of inflammatory cell recruitment and fibrosis that 
involves the BADJ, a region that represents a niche for maintenance of lung tissue stem cells, thus 
compromising the ability of the Club cells to regenerate the bronchiolar and/or alveolar epithelium. 
Furthermore, using CCSP-/- mice, we studied the mechanism by which Club cell secretory protein 
dysfunction accelerates silica-induced lung injury. Our results in wild type mice indicate that silica 
induces remodeling of the bronchiolar/alveolar duct region with apparent disorganization of 
CCSP-immunoreactive cells, reduced CCSP content, and decreased proliferation within the CCSP-
expressing cells suggesting that silica compromises the ability of these stem and/or progenitor cells 
to restore homeostasis. Our studies using CCSP-/- mice indicate that CCSP exerts anti-
inflammatory properties by inhibiting TLR responses and suppressing macrophage activation in 
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response to silica through a mechanism involving the release of Type I alpha interferon and early 
TNF-α production thus contributing to pathological lung remodeling during silica exposure. 
2.2 Materials and Methods 
Animals. All experiments were approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee. Eight to ten-week-old male C57BL/6 mice and mice lacking the 
Club cell secretory protein (CCSP-/-) gene congenic to C57BL/6J mice (Jackson Laboratory, Bar 
Harbor, ME) were given a single intratracheal (i.t.) instillation of 0.2 mg/kg freshly-fractured 
crystalline silica in 60 μl of sterile 0.9% saline. Control mice were treated with 60 μl of saline 
alone. Mice were sacrificed at 0, 3, 7, 14, and 28 d post-silica instillation. 
Bronchoalveolar Lavage (BAL) Analysis.  Total protein in BAL fluid was determined 
by a Coomassie Blue-based protein assay (ThermoScientific, Pittsburgh, PA). White blood cell 
counts and differential cell counts were analyzed as described previously [54]. Levels of TNF-α 
in the lavage fluid and cultured macrophages were assayed by ELISA (ThermoScientificThermo 
Scientific, Pittsburgh, PA).  
Lung Sample Preparation. Mice were administered pentobarbital (50 mg/kg) 
intraperitoneal (i.p.), and lungs were either gently lavaged with PBS to assess secreted CCSP 
abundance by ELISA as described previously [53] followed by fixation (naphthalene/silica 
exposure experiment) or directly open-cavity inflation fixed at 10 cm H20 using 10% formalin. 
Whole lungs were fixed overnight in 10% formalin and placed in 70% EtOH (for paraffin 
embedding) or washed in PBS/0.02% azide (for whole-mount microdissection). 
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Naphthalene and BrdU Exposure. Following silica exposure, groups of 10 female 
C57BL/6 were injected i.p. with naphthalene (225 mg/kg) dissolved in corn oil. Mice were 
inspected and weighed before and 24-48 h post-injection to assess injury severity. Subsequently, 
mice were given 6 mg/ml BrdU in sterile saline i.p. every 12 h for a total of 7 d. For animals 
sacrificed at 14 and 28 d after silica exposure, BrdU (50 mg/kg) was administered 2 h prior to 
sacrifice.  Following euthanasia, lungs were inflation fixed using 10% formalin, degassed in 30% 
sucrose, and cryopreserved using optimal cutting temperature (OCT) solution. 
Immunostaining and Whole-Mount Microdissection. Murine CCSP (in house), CGRP 
(Sigma), acetylated tubulin (ACT) (Sigma), Ki67 (Novocastra), and GFP (Abcam) antibodies were 
used for immunostaining following citrate buffer antigen retrieval. Secondary antibodies included 
appropriate species-specific Alexa488, Alexa555, and Alexa633 dyes (Invitrogen). Frozen 
sections were stained for BrdU plus airway markers, as previously described [55]. Left lung lobes 
were inflation fixed and dissected using a brightfield microscope, fine forceps, and micro-
dissecting scissors to expose the airway network to terminal bronchioles and antibody stained. 
Microdissected lungs were incubated in 10% bovine serum/0.25% fish skin gelatin for 2–3 h to 
block nonspecific antigen reactivity. Primary antibodies were added in blocking solution overnight 
(O/N) at room temperature, followed by PBS/0.2% Tween20 washes. Secondary antibodies were 
also added O/N at room temperature and washed extensively. Immunostained lung lobes were 
imaged up to 2 weeks post-staining. 
Image Acquisition and Analysis. Whole lung images were collected as previously 
described [56] using an 8000-Hz resonance detector-equipped Leica TCS confocal microscope. 
X–Y field size and Z-thickness were determined based on total lung size (≈2 cm × 1 cm × 500 μm) 
to produce a single 3D image projection. High-resolution images were collected at 400–700 Hz. 
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Digitally flattened, 3D lung images were analyzed using Volocity based on GFP signal intensity 
and patch boundary continuity to determine CCSP abundance and expression in the distal 200 
square micrometers of 14 terminal bronchioles. Regions of interest (ROI) were drawn on each lung 
image that encompassed the entire conducting airway and GFP channel intensity was used to 
distinguish GFP(+) and (−) cells. The average pixel surface area (square micrometers) of single 
cells was determined empirically and used to exclude subcellular debris. A negative reference of 
the CCSP abundance was derived from the staining of the airways of CCSP-/- mice.  All 
contiguous cells within our defined ROI were scored automatically using these parameters to 
determine BrdU labeling and/or CCSP expression. Total cell number vs. CCSP expressing/BrdU 
labeled frequency was plotted using Microsoft Excel frequency/bins parameters. In all figures, 
error bars represent the standard error of the mean (SEM). Statistical significance was considered 
when P < 0.05 based on Student's t-test. 
Hydroxyproline analysis. Dried lung tissue was acid-hydrolyzed in sealed, oxygen-
purged glass ampoules containing 2 ml of 6 N HCl for 24 h at 110 ºC and analyzed for 
hydroxyproline content using chloramine T as previously described [54].   
Quantitative real-time polymerase chain reaction (qRT-PCR) assay. To adequately 
cover the TNF-α, NF-B, Toll receptor pathways, and targeted cytokines, 84 transcripts selected 
were analyzed by qRT-PCR (Super Array Bioscience Corporation, Frederick, MD). Total RNA 
was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA) and quantity was assessed by 
absorbance (NanoDrop, Thermo Scientific, Pittsburgh, PA).  RNA (100 ng) was reverse 
transcribed (High Capacity cDNA Archive Kit, Applied Biosystems Inc., Foster City, CA) and 
cDNA was PCR amplified with primers and TaqMan Universal PCR Master Mix (Applied 
Biosystems).  Arranged into functional groups, primers (SABiosciences, Frederick, MD) included: 
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A. TNF-α ligands and receptors pathway group (20 transcripts); B. NF-B pathway group (10 
transcripts); C. Cytokine group (15 transcripts); TLR receptors (10 transcripts); Transcription 
Factors (16 transcripts); other (13 transcripts). All abbreviations are current Entrez Gene official 
symbols and official full names are presented in Appendix A table 1. The analysis was performed 
with an Applied Biosystems 7900HT System (95°C 10 min; 40 cycles 95°C, 15 s; 60°C, 1 min). 
The expression of each transcript relative to Heat shock protein 90kDa alpha (cytosolic), class B 
member 1 (HSP90AB1) transcript level was determined using the 2-CT method and normalized 
to strain-matched mice exposed to saline.  
Silica-exposed subject population. The University of Pittsburgh Institutional Review 
Board approved the procedures used in this study, and written informed consent was received from 
the subjects before inclusion in this study. Patient information was minimized to comply with 
HIPPA regulations. We identified patients that received lung transplantation at the University of 
Pittsburgh from May 1986 to July 2009. From this database, we selected patients that received 
lung transplantation for the diagnosis of silicosis (n=13). The diagnosis of silicosis or usual 
interstitial pneumonia (UIP) was unequivocally established by blind re-evaluation (S.Yousem). 
Characterization of the TNF-α, CCSP, and TLR7 and TLR9 expression in the human lungs was 
conducted by immunohistochemistry in paraffin-embedded lung tissues (4 μm) isolated from 
silicosis patients at the time of lung transplantation.   
Specific TLR and CCSP RNA expression profiling in the human lung. RNA was 
isolated from human lung (six silica exposed subjects and morphologically normal regions of lungs 
retrieved from 15 patients at the time of surgical intervention to treat their lung cancer) tissue using 
Trizol (Invitrogen, Carlsbad, CA) and purified using the RNeasy Mini kit (Qiagen). Microarray 
experiments were carried out, as described previously [57]. Briefly, RNA quantity was determined 
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on an Agilent Nanodrop and quality assessed on an Agilent 2100 Bioanalyzer, according to the 
manufacturer's instructions. Five hundred nanograms of total RNA meeting quality control criteria 
were Cy3 labeled using the Agilent Low RNA Input Linear Amplification Kit PLUS (One-Color). 
After purification and fragmentation, aliquots of each sample were hybridized to an Agilent Whole 
Human Genome 4 x 44 K microarray, sequentially washed, and scanned on an Agilent DNA 
microarray scanner. RNA expression data were analyzed with Agilent Feature Extraction Software. 
Microarray data analysis. Processed microarray data were log2-transformed and cyclic 
loss normalized, and then expressed as the difference of log of g processed signal (Agilent Feature 
Extraction) and log of geometric mean of controls. A two-fold difference in normalized expression 
value was used to estimate differential expression. Hierarchical clustering analysis was carried out 
using Scoregene statistical package (available at http://compbio.cs.huji.ac.il/scoregenes/) and 
visualized using the TreeView program [58]. The q-value, computed using the SAM (significance 
analysis of microarrays) package [59] in the R statistical environment (R Development Core Team. 
R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical 
Computing, 2006), was used to identify differentially expressed genes. The q-value represents the 
minimal false discovery rate at which an individual hypothesis test may be called significant. A 
gene was declared to be differentially expressed if the gene had a q-value < 5% in a two-way SAM 
analysis (healthy controls vs. silica) and also had a q-value < 1% in at least one of the three pairwise 
SAM analyses. 
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2.3 Results 
2.3.1  Silica induces remodeling of the bronchiolar-alveolar duct region in a mouse model 
of silicosis 
To follow remodeling events within the lung and to investigate the role of CCSP-
expressing progenitor cells in the development of silicosis, we exposed C57BL/6J mice to 200 
mg/kg of freshly fractured crystalline silica intratracheally (i.t.) and assessed tissue injury at 1, 3, 
7, 14 and 28 days post-instillation.  
Figure 1 shows terminal bronchiolar lesions associated with intratracheal silica exposure 
(200 mg/kg) in mice. C57BL/6J mice were exposed to (A, B) intratracheal saline or (C-F) 
crystalline silica and tissue obtained at (A-D) 3 d or (E, F) 28 d.  Corresponding low magnification 
(10x left) and high magnification (20x right) photomicrographs of trichrome stained lung tissue 
sections revealing either (A, B) normal terminal bronchioles, or (C-F) typical nodular lesions 
induced by silica exposure that localize to bronchoalveolar duct junctions.  
In contrast to saline-treated mice (Figure 1A, B) silica exposure of C57BL/6J mice resulted 
in the development of clearly identified lesions at 3d following silica exposure, that were localized 
at the terminal bronchiole/alveolar duct regions (Figure 1C, D). These lesions consisted of dense 
accumulations of peribronchiolar and perivascular inflammatory cells. Lesions evolved rapidly 
with time, leading to a dramatic increase in peribronchiolar collagen deposition at 28 d post-
exposure (Figure 1E, F). 
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Figure 1 Silica induces remodeling of the bronchiolar alveolar duct and lung fibrosis in C57BL/6J mice 
 
Progression to fibrotic lung disease was assessed through measurement of collagen gene 
expression, hydroxyproline content within total lung homogenate, and by histochemical 
identification of collagen deposition through trichrome staining of lung tissue (Figure 1). Silica 
exposure was accompanied by increased collagen mRNA and hydroxyproline content in the lung 
at all post-exposure times. Specifically, collagen mRNA showed a peak 7 days post-treatment, 
while hydroxyproline showed significant differences (p<0.005) at 14 and 28 d post silica exposure 
as compared to control (Figures 2A, B).  
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Figure 2 Measure of collagen gene expression and hydroxyproline content within total lung homogenate after 
silica exposure 
 
These changes were consistent with the results of collagen content assessed by the 
trichrome staining of lung tissue sections (Figure 1E, F). 
2.3.2 Altered CCSP expression in the lungs of silica-treated mice 
The impact that progressive silicotic lesions have on epithelial cells within terminal 
bronchioles and on cell proliferation within the entire lesion was assessed through analysis of 
CCSP immunoreactive cells, as a measure of the stem and progenitor cells, and the incorporation 
of BrdU into nascent DNA of proliferative cells.  
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Figure 3 Altered CCSP expression during the silica-induced remodeling of the terminal bronchioles 
 
In Figure 3, silica-induced remodeling of terminal bronchioles revealed by 
immunofluorescent colocalization of  CCSP (Green) and BrdU (Red), with DAPI nuclear 
counterstain (Blue). Corresponding low (10x) and high (20x) magnification photomicrographs 
representing airways of (A, A-1) control mice or mice receiving i.t. silica (200 mg/kg) and tissue 
were obtained at (B, B-1)3 d, (C, C-1), 14 d, or  (D, D-1) 28 d. 
Profound effects of silica exposure on the integrity of terminal bronchiolar airways were 
evident early after silica exposure, when airway epithelial cells demonstrated reduced CCSP-
immunoreactive content and interruptions on the continuous expression of CCSP were identified 
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3 d after silica exposure (Figure 3, compare control A and A-1 with 3 d silica B and B-1). These 
changes into terminal bronchioles occurred concurrently with the development of inflammatory 
nodules and early establishment of fibrotic lesions, and include extensive BrdU labeling of cells 
within the parenchyma (mitotic index for control-treated mouse 0.008 increased to 0.14 after 3 d 
following silica exposure), but not the bronchiolar epithelium (average mitotic index of 0.006 in 
control mice versus 0.005 in silica exposed mice). At 14 and 28 d, silica-treated lungs demonstrated 
persistent increases in the BrdU labeling of parenchymal regions (mitotic index of 0.10 and 0.07 
respectively) suggestive of fibroblast proliferation within developing fibrotic lesions (Figure 3, C, 
C-1, D, and D-1). 
Loss of CCSP-expression in terminal bronchioles was associated with modest 
incorporation of BrdU in the epithelium (mitotic index 0.04) and persistently decreased whole lung 
CCSP mRNA levels (Figure 4A), while a significant increase in CCSP protein levels in the BAL 
fluid of silica-treated mice was noted (Figure 4B). 
 
Figure 4 Measurement of CCSP mRNA levels in the lung and CCSP protein level in the BAL  
 
These observations suggest that silica induces secretion of CCSP into airway lining fluid 
with an associated decrease in the intracellular pool of CCSP content. 
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Silica-induced injury in C57BL/6J mice was also associated with a significant (p<0.001) 
increase in BAL total protein (Figure 5). Protein levels in BAL peaked 3 d after silica exposure 
and then decreased, although they remained significantly elevated (Figure 5). 
 
 
Figure 5 Total protein retrieved from BAL of C57BL/6J mice after silica exposure 
 
To further characterize the effect of silica on the CCSP expression in the mouse lung, we 
quantified CCSP-expressing cells within the terminal bronchioles adjacent to BADJ of control or 
silica exposed mice. This analysis demonstrated that compared to control-treated mice (with an 
average of 18 + 2 CCSP/cells) silica induces a significant (p<0.05) reduction (6 ± 3 cells at 3 d; 8 
± 1 cell at 7 d; and 12 ± 2 cells at 28 d) in the number of CCSP immunoreactive cells in the distal 
200 m of the terminal bronchioles. This decrease in the number of CCSP-expressing cells was 
associated with a corresponding increase (from 0 ± 2 cells in unexposed or saline-treated mice) in 
the number of non-CCSP expressing cells (7 ± 1 cell at 3 d; 9 ± 1 cell at 7d; 6 ± 1 cell 28 d) in 
silica-exposed mice (data not shown).  
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2.3.3 Defective epithelial repair in terminal bronchioles of silica-exposed mice 
The absence of BrdU incorporation within the CCSP-expressing population of bronchiolar 
epithelial cells following silica exposure suggests that either the proliferative capacity of the stem 
and/or progenitor pool has been compromised, or that there is a lack of mitogenic stimuli for these 
cells. However, although silica decreased CCSP expression, it did not appear to abolish the 
population of Club cells. Combined exposures of naphthalene, that specifically ablates Club cells 
and promotes epithelial repair response by inducing proliferation of naphthalene resistant CCSP 
expressing cells, and silica were used to determine whether silica exposure compromises the 
regenerative capacity of airways. Mice were sequentially exposed to naphthalene (250 mg/kg) 
(Figure 6A,B), i.t. silica (200 mg/kg, i.t.) alone (Figure 6C,D), or naphthalene (250 mg/kg) 
followed by silica (200 mg/kg, i.t.) (Figure 6E,F). Epithelial proliferation was assessed by 
measuring the BrdU-labeling index. Adjacent sections were either stained with hematoxylin and 
eosin (H&E, left panels) or dual immunofluorescence for CCSP (Green) and BrdU (Red), with 
DAPI nuclear counterstain (Blue) (right panel).  
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Figure 6 Silica inhibits epithelial repair. Silica inhibits the naphthalene-induced proliferation of resistant 
CCSP cells 
 
Naphthalene exposure resulted in the depletion of CCSP-immunoreactive progenitor cells 
(compare Figure 3A,A-1, with Figure 6A and B) and proliferation of naphthalene-resistant stem 
cells (BrdU index increased from 0.005 to 0.5) for partial restoration of the depleted progenitor 
pool by the 3 d post-exposure (Figure 6B). Exposure of mice to silica alone led to bronchiolar 
epithelial disorganization, and parenchymal proliferation after 3 d that was similar to that observed 
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previously (compare Figure 3B, B-1, and Figure 6D). Combined exposure of mice to naphthalene 
followed by silica resulted in a pattern of progenitor cell depletion similar to that observed with 
naphthalene alone (compare CCSP immunofluorescence in Figure 6B, F), an extensive 
parenchymal proliferation that was similar to silica-exposed mice (compare BrdU-labeling in 
Figure 6D, F), yet was not associated with BrdU-labeling of naphthalene-resistant CCSP-
immunoreactive cells (BrdU index was 0) (compare bronchiolar epithelial BrdU-labeling of 
CCSP-immunoreactive cells in Figure 6B, F).  These data support our hypothesis that silica 
exposure induces epithelial disorganization in the absence of epithelial proliferation that 
compromises the reparative capacity of epithelial cells within terminal bronchioles. 
2.3.4 Silica induces an enhanced inflammatory response in CCSP-/- mice 
Previous reports indicate that Club cells function in an anti-inflammatory capacity, and 
CCSP-/- mice mount an exacerbated inflammatory response to infectious or environmental agents 
[53, 60]. Therefore, we sought to determine the role of the airway epithelium in modulating the 
silica-induced inflammation by contrasting the nature of inflammatory cells recovered from BAL 
of silica-exposed C57BL/6 and CCSP-/- mice. Silica exposure of C57BL/6J mice resulted in 
significantly (p<0.001) increased levels of total inflammatory cells, retrieved from the lung via 
BAL, at 3d post-treatment as compared to untreated controls (Figure 7). BAL inflammatory cell 
counts remained elevated at 7, 14, and 28d post-silica exposure as compared to control (Figure 7). 
Compared to their congenic C57BL/6J mice, CCSP-/- mice demonstrate a lower number of cells 
recovered by BAL at baseline and the numbers of cells retrieved from the lungs of C57BL/6J mice 
were greater than in CCSP-/- mice at each time tested (Figure 7). Compared to control, silica 
treatment increases the number of cells in both mouse strains (Figure 7). 
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Figure 7 Total cells retrieved from the lung via BAL from C57BL/6J mice and CCSP-/- after silica exposure 
 
Silica exposure induced the rapid recruitment of polymorphonuclear leukocytes (PMN’s) 
within the first 24 h, and adaptation of this response to include elevated levels of 
macrophage/monocytes and lymphocytes by 3 d post-exposure and beyond (Figure 8A-F).  
Silica treatment also altered cell types recovered by BAL, shifting it from >99% 
macrophages in control mice to polymorph-nuclear (PMN) leukocytes that persisted throughout 
the 28 d after silica exposure in both C57BL/6J and CCSP-/- mice (Figure 8A-F). The percent 
PMN in BAL from CCSP-/- mice was higher than that in BAL from C57BL/6J mice at 3, 7, and 
14 d after silica. For example, CCSP-/- BAL consisted of >70% PMN as compared to ~40% in 
C57BL/6J BAL at 3 d after silica.  In contrast to PMNs, lymphocytes were identified in BAL from 
silica-exposed C57BL/6J mice, whereas these cells were not identified in silica-exposed CCSP-/- 
mice (Figure 8A-F). 
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Figure 5 Cells retrieved from the BAL of C57BL/6J mice and CCSSP-/- after silica exposure differentiated 
for type, absolute number and relative number 
 
As we described above, C57BL/6J mice showed a time-dependent increase in lung collagen 
deposition in response to silica exposure (Figure 1). Therefore, we contrasted, by real-time PCR, 
the effects of silica exposure on the rate of collagen, type I, alpha 1 (COL1A1) mRNA in the lungs 
of C57BL/6J and CCSP-/- mice. Mice (n=7) were exposed to intratracheal silica (200mg/kg) and 
recovered for the times indicated. Collagen mRNA levels were determined by qRT-PCR from the 
lungs obtained at the indicated time after silica exposure. Silica increased COL1A1 mRNA that 
peaked 7 d after silica exposure and the increase was greater in CCSP-/- mice (Figure 9). The 
asterisk indicates a significant difference by ANOVA (p < 0.05) between the CCSP-/- and the 
C57BL/6 wild type mice at the time point indicated (Figure 9).  
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Figure 6 Increased collagen type I, alpha 1 mRNA in the lungs of CCSP-/- mice  
2.3.5 Microarray analysis identifies enhancement of specific TLR expression in the lungs of 
silica-exposed CCSP-/- mice  
Our previous work characterizing the inflammatory response of Club cell-depleted or 
CCSP-/- mice to LPS indicates that, compared to wild type mice, lung macrophages from CCSP-
/- mice had enhanced TLR4 expression and increased TNF-α and IL6 production [53]. Similarly, 
we have recently reported that macrophages from the lung of silica-exposed subjects express TNF-
α protein [61]. In addition, TNF-α-mediated effects in the lung of silica-treated animals required 
activation of the transcription factor NF-κB [61]. Therefore, to ascertain whether variations in 
TNF-α, TLR or NF-κB signaling pathways and targeted cytokines, characterize the observed 
differences in the response against silica between C57BL/6J and CCSP-/- mice, we used a custom 
microarray to assess 84 gene transcripts (Appendix A Table 1) that comprehensibly represents 
the TNF-α and TLR pathways leading to NF-κB activation, in the lung of C57BL/6J or CCSP-/- 
mice following silica exposure.   
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Mice (n= 7 C57BL/6J or CCSP-/- mice/group) were treated with silica, lung mRNA was 
obtained at 3, 7, 14, and 28 d, and 40 transcript levels were assessed by qRT-PCR. In Figure 10, 
the left panel shows self-organizing map visualization of transcripts in Tree View; the right panel 
is the visualization of Mean Tendency of the transcripts measured. Values are mean + standard 
error and *p<0.05 as determined by One-way analysis of variance with all pairwise multiple 
comparison procedures (Holm-Sidak method).  
Overall, 40 of the 84 transcripts tested, including TNF-α, CCL2, IKβKG, increased within 
3 d in silica-exposed mice (Figure 10). At 28 d post-silica exposure, 39 of these 40 transcripts 
were increased (only GR1 was not significantly increased). Of the 40 transcripts measured, TNF-
α mRNA abundance increased the most (~90-fold). mRNA levels of the TNF-α receptors, 
TNFRSF1B and TNFRSF1A increased, as did transcripts TNFAIP3 and RIPK2, that are rapidly 
induced by TNF-α. All 19 TNF-α signaling pathway transcripts increased by 28 d post-silica 
exposure, and the levels of expression were similar in both C57BL/6J as well as CCSP-/- mice 
(Figure 10).  
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Figure 7 TNF-, NF-B and associated cytokines in mouse lung following silica treatment 
 
NF-κB signaling pathway transcripts also increased in C57BL/6J and CCSP-/- mouse lung 
following silica exposure, although somewhat less than the TNF-α signaling pathway. At 28 d 
post-silica, NFKB1 (p50) increased ~5-10 fold, and Rel/NF-κB family transcription factors (REL, 
RELA, RELB) increased ~5-15 fold (Figure 10).  
Also, levels of 11 out of 12 cytokine transcripts encoding factors known to control the 
production, differentiation, and function of monocytes/macrophages (CCL2 a.k.a. MCP1), and 
granulocytes (CSF3: a.k.a. G-CSF) increased significantly with disease progression, and they had 
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similar levels of expression regardless of CCSP genotype.  Furthermore, transcripts encoding IL-
1β, IFN-γ, and the downstream transcription activator, STAT1, were increased markedly (~8-20 
fold at 28 d) by silica exposure independently of CCSP genotype. 
Twenty transcripts, including members of the TLR, significantly increased in the lungs of 
silica exposed CCSP-/- mice; most of them were not found to change in C57BL/6 mice in response 
to silica (Figure 11A). Prominent among these transcripts were TLR 6, 7, 8, 9, MYD88, 
SLC20A1, ICAM1, SMAD3, JUN markedly increased (~10-35 fold at 14 and 28 d respectively) 
(Figure 11A). TLR9 transcript levels increased more in CCSP-/- mouse lung than in strain-
matched C57BL/6J mouse lung (Figure 11B). 
 
Figure 8 Toll receptor expression increased in CCSP-/- mouse lung following silica treatment  
 
Immunohistochemistry was used to validate the altered expression of these proteins in the 
lung of CCSP-/-, but not in C57BL/6J, mice exposed to silica. Among the TLR’s showing CCSP-
dependent silica-induced changes in their expression, TLR7 and TLR9 immunoreactivity was 
dramatically increased in macrophages located in areas of inflammation surrounding the terminal 
bronchioles (Figure 12A, B) as described in Figure 1. 
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Figure 9 Immune-histological staining of the lungs of silica exposed CCSP-/- localized expression of TLR7 
and TLR9 proteins to macrophages in the lungs of these mice 
 
To determine whether the in vivo responses to silica were due to intrinsic differences in 
the response of macrophages from CCSP-/- mice to silica exposure, we cultured macrophages from 
BAL or bone marrow of wild type and CCSP-/- mice and expose them to silica in vitro.  Western 
blot analysis of silica-exposed macrophages coupled with the detection of TLR proteins (4,6,7,8,9) 
revealed that silica-induced expression of TLR 7 and 9 proteins in primary macrophages (Figure 
13) and that the level of induction was higher in macrophages from BAL of CCSP-/- than C57BL/6 
mice.  
 
Figure 10 Western blot analysis of proteins isolated from CCSP-/- or C57BL/6 macrophages from BAL 
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2.3.6 CCSP-/- macrophages demonstrate enhanced Interferon I alpha and TNF-α 
production in response to silica 
Our previous work identified the lung macrophage as the principal source of TNF-α in the 
lung in response to silica [61]. However, recent publications investigating the role of the 
inflammasome in the pathogenesis of silicosis indicate that exposure of unprimed macrophages to 
silica does not result in TNF-α production and that these cells would require priming (i.e., LPS) 
prior to the release of this cytokine [19, 62]. Our current data show that, although we identify 
similar increases in TNF-α RNA expression in the lungs of silica exposed mice from both mouse 
strains, we find that TNF-α release is significantly elevated in BAL fluid from CCSP-/- mice 
relative to exposed wild type mice 24 h after silica exposure (Figure 14).  
 
 
Figure 11 Silica induces TNF- production in lungs of CCSP-/- but not in C57BL/6J wild type mice 
 
Thus, compared to control-treated mice, CCSP-/- mice, but not C57BL/6J mice, release 
TNF-α protein (3200 ± 500 pg/ml) in BAL obtained at 24 h following silica exposure, (Figure 
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14). Consistent with an enhanced ability by non-primed CCSP-/- macrophages, we find that these 
cells release significant (p<0.001) amounts of TNF-α when challenged in vitro 4 h with a broad 
range concentration (from 50 to 200 μg/cm2) of silica (Figure 15). In contrast, C57BL/6J derived 
macrophages do not release TNF-α at 4 h after exposure to a broad range of silica concentrations, 
although they release significant concentrations of TNF-α in response to LPS (Figure 15). 
 
Figure 12 Enhanced production of TNF-α by CCSP-/- and C56BL/6J macrophages 
 
But how does CCSP deficiency impact TNF-α release by macrophages? Our data show 
that silica predominantly enhances expression, in lungs and macrophages of CCSP-/- mice, of 
members of the TLR receptors family, such as TLR7 and TLR9, that are localized exclusively in 
the endosomal compartment [63]. Therefore, we reasoned that CCSP-/- macrophages could use a 
TLR7/9-mediated mechanism to induce the release of inflammatory mediators such as TNF-α in 
non-primed macrophages. TLR 7/9-mediated signaling, leading to the production of inflammatory 
mediators, is dependent on the recruitment of adaptor protein MyD88 expression of which is 
increased in the lungs of CCSP-/-, but not C57BL/6J mice (Figure 11). We speculate that elevated 
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MyD88 expression in macrophages of CCSP-/- mice promotes the activation of transcription 
factors, the production of type I IFN (alpha and beta) proteins, and the subsequent stimulation of 
IFN-sensitive genes such as TNF-α [63]. We find that CCSP-/-, but not C57BL/6J macrophages, 
exhibit a time-dependent release of type Iα IFN starting at 1 h after stimulation with silica (Figure 
16). Importantly, no changes were observed in the expression of type I β IFN by macrophages 
from either mouse strain following silica exposure (data not shown). These data suggest that 
endosomal TLR receptors mediate the altered inflammatory response observed in CCSP-/- 
macrophages to silica. 
 
Figure 13 Enhanced production of Interferon I by CCSP-/- macrophages 
2.3.7 CCSP expression is reduced, and TLR receptor expression is enhanced in the lungs of 
silica-exposed human subjects  
To determine the relevance of the data observed in the lungs of silica-exposed CCSP-/- 
mice in the pathogenesis of silicosis, we studied the expression of members of the secretoglobin 
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and TLR family of genes within explanted lung tissue of 13 patients with silicosis at the time of 
lung transplantation. Of these samples, total RNA was isolated, and gene expression evaluated by 
microarray analysis. Total RNA isolated from the silicotic lung tissue of six patients was contrasted 
with total RNA isolated from morphologically normal regions of lungs retrieved from 15 patients 
at the time of surgical intervention to treat their lung cancer. Microarray analysis revealed that 
compared to healthy lungs, the expression of secretoglobin proteins and CCSP (SCG1A1) in 
particular is decreased in the lungs of silica-exposed subjects (Figure 17A). In addition, our 
analysis of the TLR expression in the lungs of silica exposed subjects closely resembles the pattern 
of expression identified in the lungs of CCSP-/- mice and TLR 1, 2, 6, 7, and 8 transcripts increased 
in silicosis subjects when compared to controls (Figure 17B). Although TLR9 transcript levels 
were greater than those of control, these levels did not achieve statistical significance (p<0.05). 
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Figure 14 CCSP expression is reduced, and TLR receptor expression is enhanced in the lungs of silica-
exposed human subjects 
 
Subsequently, TNF-α and TLR7 localization were determined by performing 
immunostaining of lung tissues isolated from subjects suffering from silicosis at the time of lung 
transplantation.  In all 6 silicosis patients, large areas of the lung parenchyma were replaced by 
coalescence of silicotic nodules (Figure 18). These nodules contain fibrous material, had few cells 
and did not demonstrate TNF-α or TLR7 immunostaining.  
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Figure 15 Characterization of the TNF-α and TLR7 expression in the human lungs conducted by 
immunohistochemistry 
 
Figure 16 TLR 9 expression in the lung of silica exposed subjects  
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In contrast, TNF-α immunostaining was evident in preserved regions of the lung 
parenchyma adjacent to the silicotic nodules, where the expression was confined primarily to 
silica-laden macrophages (Figure 18A,A1). Sequential section localized the expression of TLR7 
(Figure 18B,B1) and TLR9 (Figure 19) to the same macrophages that expressed TNF-α. 
Therefore, these findings closely reproduce the TLR expression observed in the CCSP-/- mice. 
Figure 18 shows the immunochemistry signal with the anti-TNF-α antibody at (A) low (x200) and 
(A1) high (x400) magnification and with the anti-TLR7 antibody at (B) low (x200) and (B1) high 
(x400) magnification. Figure 19 shows the immunochemistry signal with anti-TLR9 antibody at 
(A) Low (x200) and (B) high (x400) magnification. 
2.4 Discussion 
Silicosis remains a serious occupational and environmental lung disease [10].  The 
worldwide incidence and prevalence of silicosis is uncertain but is increasing in developing 
countries [64]. For example, the silicosis burden in China is growing (with  ~7-10,000 new 
cases/yr) and is extensive (>500,000 cases resulting in ~24,000 deaths/yr) [64]. In the United 
States, the incidence and prevalence of silicosis are under-estimated, as silicosis is not a reportable 
disease and under-recognized [65]. Approximately 1.7 million people in the US are occupationally 
exposed to silica [66-69], and as many as 119,000 are exposed above permissible levels [66-69] 
with the majority of these individuals employed in mining, construction, or maritime activities. 
The economic burden of silicosis to our society is enormous and recent studies by the National 
Institute for Occupational Safety and Health (NIOSH) tracking the death rates of silicosis patients 
 
 39 
across the nation calculated that the near 2000 deaths (1968-2005) in patients under 65 years of 
age account for a loss of 17,130 years of potential life [70]. 
Although preventive measures have significantly decreased the mortality attributable to 
silica, no specific therapy, including lung transplantation, appears to be successful in these patients 
[66, 70]. Therefore, understanding the pathogenic mechanisms of silicosis is fundamental to 
identify targets that predict individual susceptibility or provide a window of opportunity for 
therapeutic intervention. 
CCSP has been identified as a biomarker to screen the early toxic effects of 
environmentally-induced lung injury, including in silicosis [71]. CCSP is the main secreted 
product of Club cells, and under normal conditions, it achieves high concentrations in respiratory 
secretions [49]. BAL concentration of CCSP in healthy subjects average between 1-2 mg/l, but 
because BAL techniques result in a 100-fold dilution approximately of the epithelial lining fluid, 
CCSP concentrations at the surface of the airways can be estimated at 100 mg/l [49]. CCSP is 
produced as a homodimer of 70 amino acid subunits, with a molecular weight of 15,840 Da, and 
diffuses from the lung into the peripheral circulation. Although CCSP mRNA is present in tissues 
outside the lung, such as the prostate, there is consensus that the bulk of the circulating protein is 
produced by the airway epithelium of the lung [72]. Serum CCSP levels in healthy, non-smoker, 
individuals are reported in the range of 10-15 μg/l; thus a large concentration gradient is 
responsible for the movement of this protein from the lung into the blood [73]. The integrity of the 
alveolar-capillary membrane is a crucial determinant of this equilibrium, and the situation in which 
this barrier is disrupted (i.e., acute lung injury) results in increased serum concentrations [49]. An 
example of this is the rapid increased in serum CCSP observed on cyclist exposed to low 
concentrations of ozone [60] or the increase in serum concentration of CCSP in LPS treated rats 
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at a time point when CCSP concentrations in BAL and lung homogenates, as well as CCSP mRNA 
levels, were depressed [74]. These observations indicate that the assay of serum CCSP is a possible 
indicator of defects in the lung epithelial barrier permeability [60].  
Serum CCSP concentration is decreased in a dose-dependent manner by tobacco smoking. 
Similarly, serum concentrations of CCSP are decreased in chronic diseases such as sarcoidosis, 
asthma, and pulmonary fibrosis [49]. A significant reduction in CCSP has been identified as early 
as 3 d after the exposures of rats to silica [50]. A significant reduction in serum CCSP is present 
in workers exposed to crystalline silica for less than 2 years and without clinical evidence of lung 
impairment [43]. Similar to these findings, we identify a decreased mRNA for CCSP in the lungs 
of silica-exposed subjects. However, large variations were observed in the level of expression 
between the individuals, and the number of silica-exposed subjects (n= 6) was small. Taken 
together, these data support the utility of serum CCSP as a suitable biomarker in silicosis; still, 
they do not clarify the mechanisms by which silica alters the CCSP expression in the lung, nor do 
they clarify the subsequent role that this altered CCSP expression plays in the pathogenesis of 
silicosis. 
In this study, we provide evidence indicating that silica induces progressive inflammation 
of the small airways of the mouse lung, encasing the BADJ, where it compromises the proliferation 
of Club cells that harbor the putative capacity to regenerate both secretory and ciliated epithelial 
cell types. Because of the injury to Club cells, silica also decreased total lung CCSP mRNA, CCSP 
immunostaining BADJ cells, and increased CCSP protein detected in BAL. We are not able to 
determine whether reduced CCSP mRNA, observed in the total lung, is the result of excessive loss 
of in the number of CCSP positive cells or if it represents a change in the expression of CCSP 
mRNA by individual cells. Our current findings also indicate that silica compromises the ability 
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of CCSP expressing cells to proliferate. Our previous findings indicate exacerbated fibrotic and 
inflammatory response to silica in the lungs of CCSP-dnIκB transgenic mice, that experience 
increased epithelial apoptosis of CCSP expressing cells as they express, in Club cells, a mutant 
IκB that cannot be phosphorylated and therefore does not allow the nuclear translocation and 
activation of NF-κB [10]. Together, these findings favor a scenario in which silica is inducing cell 
death of CCSP expressing cells with the associated secretion of CCSP protein from Club cells into 
the luminal surface of the epithelium, thus explaining the increased levels of protein identifying in 
the BAL fluid of CCSP (figure 4) in silica exposed C57BL/6J mice at times when the mRNA 
coding for this protein is still down-regulated in the lung (figure 4). 
Consistent with an anti-inflammatory role for CCSP in the pathogenesis of silicosis, we 
find that CCSP-/- mice exhibit an enhanced early TNF-α expression in BAL. This was somewhat 
unexpected in that untreated CCSP-/- mice exhibit a lower total number of inflammatory cells in 
BAL compared to their C57BL/6J counterpart (figure 7). However, when challenged with silica, 
CCSP-/- mice maintain a high total cell number compared to control throughout the 28 d tested, 
consisting of a high total amount of macrophages and neutrophils (as well as a higher percentage 
of PMN), and absent lymphocytes in their BAL. These data are in agreement with previous reports 
demonstrating exacerbated lung inflammation in the lungs of CCSP-/- mice to other environmental 
challenges such as ozone and LPS [74, 75]. Microarray analysis shows that compared to lungs 
from C57BL/6J mice, lungs from silica exposed CCSP-/- mice exhibit, in an exclusive manner, 
higher expression of a cluster of genes in the toll-like receptor family (including TLR6, 7, 8, 9) 
involved in the regulation of the innate immune response. Similar to these findings in mice, we 
also find statistically significant increases in TLR6, 7, and 8 in the lungs of 6 silica-exposed 
subjects when compared to the expression of these genes in 15 control subjects.  Subsequently, 
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functional analysis reveals that silica induces expression of TLRs 7 and 9 protein and exacerbated 
production of TNF-α by primary macrophages from CCSP-/- mice but not C57BL/6J mice.   
A role for TLRs was observed in CCSP-/- mice exposed to LPS in which an enhanced cell 
surface expression of TLR4 favors the release of a higher concentration of TNF-α by the alveolar 
macrophages of these mice [53].  However, silica exposure did not alter TLR4 expression (RNA 
or protein) in either human or mouse lung (Figure 11).  In agreement with these data, Beamer et 
al. indicate that silica suppresses the ability of LPS to promote dendritic cell activation by 
modulating toll-like receptor ligand-induced activation of these cells [21].  Furthermore, the 
finding reported by Snyder et al. that the inflammatory phenotype of CCSP-/- macrophages could 
not be corrected in vitro with fractionated CCSP enriched BAL indicates that rather than exerting 
a direct role in regulating macrophage responsiveness CCSP deficiency causes an intrinsic 
alteration to the population of macrophages [53].   
But what is the nature of this intrinsic alteration observed in CCSP-/- macrophages in 
response to silica?  The group of TLRs that increased their expression in the lungs tissues of CCSP-
/- mice and silica-exposed subjects are predominantly associated with the intra-cytoplasmic 
recognition and processing of pathogen-associated molecular patterns (PAMPs).  Therefore, we 
reasoned that the intrinsic alteration responsible for the increased reactivity to silica could be 
related to the intracellular handling of silica by the macrophages rather than cell surface events.  
This hypothesis is consistent with the observations that stimulation of macrophages by silica 
requires the phagocytosis of silica particles [76, 77]. Thus, following phagocytosis of silica 
particles CCSP-/-, but not C57BL/6J-derived macrophages demonstrate increased expression of 
TLR7 and 9 moieties shortly after silica ingestion (Figure 11).  This is followed by secretion 
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(observed as early as 1 h after stimulation with silica particles) of type Iα, but not type Iβ, interferon 
that preceded the release of interferon sensitive TNF-α [63].  
In summary, the present work indicates that silica injures the airway epithelium of 
bronchoalveolar duct junctions, compromising the repairability of CCSP expressing cells and 
decreasing the expression of CCSP protein in the lung.  Consistent with an anti-inflammatory 
function for CCSP, CCSP-/- mice demonstrate enhanced inflammatory responses, accompanied 
by enhanced expression of endoplasmic TLR proteins in macrophages that can promote the release 
of interferon I alpha and the production of TNF-α by these cells.  These studies also suggest that 
prospective measurements of CCSP levels in serum and respiratory secretions may constitute a 
valid biomarker to determine enhanced susceptibility to inflammatory responses to silica.  Further 
studies are needed to validate this concept and to comprehend better the interactions between the 
epithelium and the regulation of the innate immune responses in the lung during environmental 
injury. 
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3.0 Metabolic Adaptation of Macrophages as Mechanism of Defense Against Crystalline 
Silica 
3.1 Introduction 
Crystalline silica is one of the most abundant minerals on Earth. More than 230 million 
individuals around the world, and more than 2 million workers in the United States, predominantly 
in construction and mining occupations, are exposed to silica every year [2, 3]. Inhalation of 
crystalline silica leads to the development of silicosis, a progressive pneumoconiosis characterized 
by lung inflammation and fibrosis, for which no specific therapy is available. Silicosis is associated 
with increased risk of tuberculosis, lung cancer, chronic obstructive pulmonary disease (COPD), 
kidney disease, and autoimmune disease, and these health risks remain elevated even after silica 
exposure has ceased [3, 10, 11].  
Macrophages are fundamental to the pathogenesis of silicosis. Similar to live bacteria, 
silica is phagocytosed by macrophages into phagosomes. Subsequently, macrophage activates 
pattern recognition receptors (PRRs) and the NLRP3 inflammasome, and release cytokines such 
as IL-1β, TNF-α, and Interferons, critical mediators of the pathogenesis of silicosis [19]. In contrast 
to bacteria, silica particles cannot be degraded, and the persistent activation results in an increased 
NADPH oxidase (Phox) activation, and mitochondrial ROS production that ultimately leads to 
macrophage cell death and release of silica particles that perpetuate inflammation [3, 44, 78, 79]. 
Activated macrophages exhibit altered immuno-metabolism, intracellular metabolic changes that 
govern immune effector mechanisms, such as cytokine secretion. For example, lipopolysaccharide 
(LPS)-stimulated macrophages demonstrate enhanced glycolysis and increased secretion of IL-1β 
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and TNF-α [46-48]. Inhibiting glycolysis or blocking succinate dehydrogenase (SDH), an enzyme 
that links glycolysis and the ETC, in LPS-stimulated macrophages inhibits IL-1β, but not TNF-α, 
production proving that the metabolic pathway is specifically involved in the cytokine production 
[47]. 
Despite decades of research, the nature of the macrophage metabolic response induced by 
silica, its contribution to cytokine specification, and the pathogenesis of silicosis are not well 
understood.  In the current study, we applied state of the art techniques, such as high-resolution 
respirometry and liquid chromatography-high resolution mass spectrometry (LC-HRMS), to 
determine the effects of silica on mitochondrial respiration, and the changes in central carbon 
metabolism of silica-exposed macrophages. Specifically, we characterized the metabolic 
reprogramming of silica-stimulated macrophages, in terms of alteration in glycolysis, TCA cycle, 
mitochondrial respiration, and ETC activity, to correlate their contribution to cytokine 
specification. Using macrophage cell lines, we reported significant differences in metabolic 
responses of macrophages stimulated by silica and LPS. We found that similar to LPS exposure, 
silica increases glucose uptake and enhances glycolysis in macrophages.  
In contrast to LPS, which induces accumulation of TCA intermediates such as citrate, 
succinate, and itaconate, silica reduces the absolute intracellular amount of TCA intermediates 
succinate and itaconate below control levels. Silica also induces specific ETC adaptations, 
enhanced mitochondrial complex II (CII) activity, and downregulation of mitochondrial complex 
I (CI) activity via reductions of the CI specific protein Ecsit, that are required for macrophage 
survival to silica-induced cytotoxicity.  
These metabolic responses correlated with the observed differences in macrophage 
production of inflammatory cytokines in response to LPS and silica. Thus, although RAW 264.7 
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macrophages enhanced IL-1β and TNF-α production in response to LPS or silica, only LPS-
stimulated RAW 264.7 macrophages exhibited HIF-1α stabilization under normoxic conditions, 
activation of the caspase 1, and malonylation of GAPDH in a time-related manner that preceded 
the release of IL-1β and TNF-α. Also, we observed differences in the RAW 264.7 macrophages 
accumulation of itaconate that correlate, inversely, with the transcription and release of interferon-
beta (IFN-β) in response to LPS or silica 
3.2 Materials and Methods 
Cell culture 
The mouse macrophage cell lines RAW 264.7 and IC-21 were purchased from the 
American Type Culture Collection (Rockville, MD) and were cultured in DMEM medium (Gibco 
BRL, Rockville, MD) or RPMI 1640 (ATCC, Rockville, MD) respectively, supplemented with 
10% fetal bovine serum, 100Uml/1 of penicillin G and 100 mg/ml/1 streptomycin and grown at 
37°C in 5% CO2.  
Silica particles, antibodies, and reagents 
Crystalline silica was isolated from environmentally relevant sources and characterized at 
the National Institute of Occupational Safety and Health (NIOSH, Pittsburgh PA) using a Multi-
Cyclone Sampling Array (MCSA) as previously described [79, 80].  α-quartz, average size of 1.7 
μm, was also obtained from U.S. Silica (Berkeley Springs, WV). Particles were subjected to 
sedimentation, according to Stokes’ law, acid hydrolyzed and baked overnight (200°C, 16 h) to 
inactivate endotoxin contamination. 
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Primary antibodies: Anti-HIF-1α (cat.# NB100-449), anti-GAPDH load control (cat# 
MA5-15738), were obtained from Thermo Fisher; Total OXPHOS Rodent WB Antibody cocktail 
(cat#ab110413), anti-Ecsit antibody (cat# ab21288), from Abcam; anti IL-1β/IL-1F2 Antibody 
(cat# AF-201-NA) from R&D System Inc, anti-caspase-1 p10 (M-20) (cat# SC-514) and A/G plus 
agarose beads (cat# sc-2003) and normal mouse IgG (cat# sc-2025) from Santa Cruz 
Biotechnology, anti b-actin (cat# 4967) from Cell Signaling Technology, anti malonyl lysine (cat# 
PTM-901) from PTM Biolabs, anti-GAPDH (cat# MAB374) from EMO Millipore Corp USA. 
Secondary antibodies: anti-goat IgG (cat# ab6741) from Abcam, Anti-mouse IgG HRP-
linked antibody (cat#7076) and anti-rabbit IgG HRP linked antibody (cat# 7074S) from Cell 
Signaling; ATP Synthase (cat# MA1-930) and anti-mouse Alexa 488 (cat# A11029) from 
Invitrogen, Anti-rabbit Cy3 (cat# 111-164-144) from Jackson Immuno. 
Lipopolysaccharides from Escherichia coli 0111:B4 (cat# L4391-1MG), L-Lactate 
Dehydrogenase (L-LDH) from rabbit muscle (cat# 10127230001), and Sodium L-Lactate (cat# 
71718) were purchased from Millipore-sigma (St Louis, MO, USA).  
Pierce™ RIPA Buffer (cat# PI89900), Halt™ Protease and Phosphatase Inhibitor and 
Propidium Iodide-1.0 mg/mL Solution in Water (cat# P3566) were from Thermo Fisher. The D-
glucose (U-13C6, 99%, cat# CLM-1396-0) was purchased from Cambridge Isotope Laboratories 
(Andover, MA, USA). Annexin V-FITC Apoptosis Kit Plus (cat # K201-100) was purchased from 
Biovision.  
Detection of cell death 
Cell death was analyzed by evaluating (flow cytometry) Annexin V binding and the 
exclusion of Propidium iodide by macrophages, as previously described [81].  
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Lactate Dehydrogenase assay 
Lactate dehydrogenase (LDH) in the supernatant of exposed cells was measured using a 
commercial lactate dehydrogenase release assay (Sigma-Aldrich, TOX7) according to the 
manufacturer’s instructions. The absorbance was measured spectrophotometrically at a 
wavelength of 490 nm, using Cytation 5 Cell Imaging Multi-Mode Reader Biotek. 
Lactate Assay 
Lactate concentration in the supernatant of exposed cells was assessed using a modification 
of the commercially available lactate assay (Sigma-Aldrich, TOX7). The reaction is based on the 
oxidation of lactate by lactate dehydrogenase (LDH). Cell supernatant was incubated with an equal 
volume of LDH (f.c. 1M), 1x LDH assay cofactor preparation, and LDH Assay Dye Solution 
(cat#L2277). Absorbance was acquired spectrophotometrically at a wavelength of 490 nm, using 
Cytation 5 Cell Imaging Multi-Mode Reader Biotek. 
ETC Assays 
Respirometric Experiments. An Oxygraph O2k Polarographic instrument (Oroboros 
Instruments, Innsbruck, Austria), equipped with a Clark-type electrode for high-resolution 
respirometry, was used to measure oxygen fluxes and concentrations. Dulbecco's Modified Eagle's 
medium (DMEM) without glucose (2.1 mL) was added to each chamber and equilibrated for 20 
minutes before the addition of cell suspension (2.5 x 106cells/ml) (prepared as described above) 
into the Oxygraph chambers (sealed from the atmosphere) at 37°C. Oxygen turnover was 
examined by the addition of succinate (final concentration, f.c., 10 mM).  
Substrate-uncoupler-inhibitor titration (SUIT) assay. SUIT protocol was used for the 
analysis of oxidative phosphorylation, to study respiratory control in a sequence of coupling and 
pathway control states induced by multiple titrations. After equilibration of the cells into the 
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chamber the substrates, inhibitors or uncoupler were added according to the following protocol: 
rotenone (f.c. 0.5 µM) to inhibit complex I, succinate (f.c., 10 mM) to stimulate complex II, ADP 
(f.c. 1mM) to measure the total respiratory capacity, Carbonyl cyanide m-chlorophenyl hydrazone 
CCCP (f.c. 0.05 µM) to determine the state of coupling of complex III, IV, V, antimycin A (f.c. 
2.5 µM) to inhibit complex III (Sigma Aldrich). Hydrogen Peroxidase (H2O2) flux was assessed 
simultaneously using the H2O2-sensitive probe Amplex UltraRed, by the addition of Amplex Red 
(f.c. 10 µM) and Horseradish-Peroxidase (HRP) (f.c. 1U/ml) (Sigma Aldrich) following the 
variation of the resorufin concentration while performing the SUIT assay protocol. Additions by 
gas-tight syringe into the sealed Oxygraph chambers. Respirometric data analysis was carried out 
with DatLab 7 software provided by Oroboros. 
Complex I Assay  
Mitochondrial Complex I activity was measured spectrophotometrically (DU-530; 
Beckman Coulter). Mitochondrial pellets were lysed in 0.05mM potassium/phosphate buffer 
(0.05mM, pH 8) containing NADH (10.0 mM), K3Fe(CN)6  (25mM), a phospholipid supplement 
(0.005% n-Dodecyl-β-D-Maltopyranoside from Anatrace), Antimycin A (2.5mM) and 320 μg 
protein from the cell pellet by following the oxidation of NADH at 420 nm initiated by K3Fe(CN)6 
at 30-38 C. Data were acquired for 100 seconds after initiation of the reaction. 
Complex II Assay  
Mitochondrial Complex II activity was measured spectrophotometrically (DU-530; 
Beckman Coulter), using a modification of the commercially available Complex II Enzyme 
Activity Microplate assay Kit (colorimetric) (Abcam, cat# ab109908). Proteins were extracted in 
PBS and detergent, then lysed in complex II activity buffer, lipid/phospholipid mix, 2,6-
dichloroindophenol (DCIP), and Ubiquinone-2, and succinate as provided by the kit and 300 μg 
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protein from the cell pellet. The reaction was followed by measuring the decrease in absorbance 
at 600nm for 100 sec at room temperature. The activity of complex II was expressed as 
mAbs/min/μg protein.  
Protein immunoprecipitation and western blotting 
A total of 10x106 cells/condition were lysed with 1 ml of ice-cold Pierce™ RIPA Buffer 
with protease inhibitors and disrupted by repeated aspiration through a 21 gauge needle. Protein 
concentration was measured using BCA protein assay (cat# 23225, Thermo Fisher) and normalized 
across samples prior to immunoprecipitation. 500 μl of lysate was pre-cleared with 1.0 μg of 
appropriate control IgG (normal mouse) and 20 μl A/G PLUS agarose, for 30 minutes at 4°C. For 
GAPDH immunoprecipitation, 100-500 μg of total cellular protein were incubated with 2 μg of 
primary antibody for 1 hour at 4°C, then added 20 μl A/G beads overnight and incubated overnight 
at 4°C on a rocker platform. Immunoprecipitates were collected by centrifugation at 1000xg for 5 
minutes at 4°C, the liquid was removed and the pellets were washed 4 times with PBS. Immune 
complexes were eluted by adding 40 μl of 1x electrophoresis sample buffer, boiled for 5 minutes 
at 95°C and analyzed by SDS-PAGE. 
Protein samples from cultured cells were prepared by lysis with RIPA buffer with protease 
inhibitors. Protein concentration was determined using the BCA protein assay (cat# 23225, 
Thermo Fisher). 20-50 μg protein samples were separated by SDS-PAGE and transferred onto a 
PVDF membrane via iBlot (Invitrogen) transfer. Membranes were blocked in 5% non-fat milk and 
incubated with primary antibodies and horseradish peroxidase (HRP)-conjugated secondary 
antibodies. Membranes were probed with the respective antibodies and visualized using 
SuperSignal West Femto Maximum sensitivity substrate (cat# 34095, Thermo Scientific) and 
Amersham Imager 600.  
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Immunofluorescence staining 
RAW 264.7 macrophages were plated on coverslips, allowed to grow overnight and 
stimulated with LPS (1 ng/ml) or Silica (50 μg/cm2) with or without priming with LPS (1 ng/ml) 
for 24h. Cells were fixed with 2% paraformaldehyde in PBS for 15 minutes at 4 degrees. Cells 
were permeabilized with 0.1% Triton X-100 in PBS with .5% BSA for 15 min. Cells were blocked 
with 2% normal goat serum for 45 minutes and stained overnight for primaries for ECSIT 
(ab21288, Abcam) with ATP Synthase(MA1-930, Invitrogen) and HIF-1 alpha (NB100-449, 
Novus) with ATP Synthase. Corresponding secondary antibodies anti-rabbit Cy3 (111-164-144, 
Jackson Immuno) and anti-mouse Alexa 488 (A11029, Invitrogen) were added for one hour. 
Nuclei were stained with Hoechst (B2883, Sigma) 1mg/100ml dH20 for one minute, washed in 
PBS, and mounted in gelvatol. Large area scan images were obtained on Nikon A1 confocal 
microscope with NIS Elements v4.4 at 60x magnification.  
Isolation of mitochondria 
Mitochondria were isolated from control, silica, or silica plus LPS-stimulated RAW 264.7 
macrophages using a mitochondria Isolation Kit for Cultured Cells (cat# 89874, Thermo Fisher) 
following manufacturer instructions.  
Enzyme-Linked Immunosorbents Assay 
Cytokines concentration in cell supernatants were measured using ELISA kits for mouse 
IL-1β, TNF-α and IFN-β, according to the manufacturer’s instruction, Mouse IL-1β ELISA 
MAX™ Standard (cat# 432601) or Mouse TNF-α ELISA MAX™ Standard (cat#430902), both 
purchased by Biolegend. Mouse IFN-beta DuoSet ELISA (cat#DY8234-05) was purchased by 
Bio-Techne. Optical density values were measured at a wavelength of 450 nm, using Cytation 5 
Cell Imaging Multi-Mode Reader Biotek. 
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RNA analysis 
Total cellular RNA was isolated from cells using TRIZOL reagent (Invitrogen) following 
the manufacturer's instructions. The concentration of total RNA was quantified at an absorbance 
of 260nm. Real-time qPCR was performed on RNA by an RT-PCR using TaqMan RNA-to Ct 1-
Step Kit (Applied Biosystems), according to the manufacturer’s instructions, using 500 ng of RNA 
as a starting material, in a total reaction volume of 10 µL PCR conditions were following: 15 min 
48°C, 10 min 95°C, followed by 40 cycles with 15 sec at 95°C and 1 min at 60°C in the ABI 7300 
real-time PCR system. The qRT-PCR was performed on RNA using probes specific for TNF-α 
(IDMm00443258_m1), IL-1β (ID Mm00434228_m1) and IFN-β (Mm00439552_s1) (Thermo 
Fisher). The GUSB (ID Mm01197698_m1) or GAPDH (Mm9999915_g1) (Thermo Fisher) was 
used for normalization; fold change was calculated using the equation described in the last. The 
Ct was calculated subtracted the Ct of GUSB or GAPDH from the Ct of the gene of interest. 
Ct was calculated by subtracting the Ct of the reference sample from Ct of Control sample. 
Fold change was generated using the equation 2-. 
Metabolic assay 
Stable isotope labeling. 13C tracer analysis and high-resolution mass spectrometry were 
used to discern subtle shifts in energy substrate metabolism in specific reactions through the 
detection and quantification of metabolite isotopologues. RAW 264.7 macrophages (1x106/well 6-
wells plate) were activated with LPS (10 ng/ml) or silica (50 µg/cm2) dissolved in DMEM without 
glucose, supplemented with 12C- or U13C-labeled glucose (4.5 mg/l), 5% Fetal Bovine Serum 
dialyzed. Experiments were conducted n = 6/condition. Controls included vehicle control and the 
12C glucose control for each treatment condition. 
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Untargeted liquid chromatography-high resolution mass spectrometry (LC-HRMS). 
Sample preparation. Metabolic quenching and polar metabolite extraction were performed using 
ice-cold 80% methanol/0.1% formic acid at a ratio of 500 µL per 1x106 adherent cells. An internal 
standard mix containing (D3)-creatinine and (D3)-alanine, (D4)-taurine, and (D3)-lactate (Sigma-
Aldrich) was added to the sample lysates at a final concentration of 100 µM. After 3 minutes of 
vortexing, the supernatant was cleared of protein by centrifugation at 16,000 x g. Cleared 
supernatant (3 µL) was subjected to online separation and analysis. LC-HRMS Method. Analyses 
were performed by untargeted LC-HRMS. Briefly, samples were injected via a Thermo Vanquish 
UHPLC and separated over a reversed-phase Thermo HyperCarb porous graphite column 
(2.1×100mm, 3μm particle size) maintained at 55°C. For the 20 minute LC gradient, the mobile 
phase consisted of the following: solvent A (water/0.1% FA) and solvent B (ACN/0.1% FA). The 
gradient was the following: 0-1min 1% B, increase to 15%B over 5 minutes, increasing to 98%B 
over 5 minutes, and held at 98%B for five minutes before equilibration to starting conditions. The 
Thermo ID-X tribrid mass spectrometer was operated in positive and negative ion mode, scanning 
in Full MS mode (2 μscans) from 100 to 800 m/z at 70,000 resolution with an AGC target of 2 x 
105. Source ionization setting was 3.0 kV/2.4kV spray voltage for positive and negative mode, 
respectively. Source gas parameters were 45 sheath gas, 12 auxiliary gas at 320°C, and 8 sweep 
gas. Calibration was performed prior to analysis using the PierceTM FlexMix Ion Calibration 
Solution (Thermo Fisher Scientific). Alignment and peak area integration were then extracted 
manually using Quan Browser (Thermo Fisher Xcalibur ver. 2.7). Atomic percent enrichment was 
calculated using the established Mass isotopomer multi-ordinate spectral analysis (MIMOSA) 
method to remove the natural 13C abundance background [82]. 
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Transmission electron microscopy (TEM) analysis 
At one, two, and four hours after exposure, cells were fixed in 2.5% glutaraldehyde in 
phosphate-buffered saline (PBS) and post-fixed in 1% osmium tetroxide in PBS, dehydrated 
through a graded series of alcohols and embedded in Epon (Energy Beam Sciences, Agawam, 
MA). Thin (70-nm) sections were cut using a Reichert Ultracut S (Leica, Deerborn, MI), mounted 
on 200-mesh copper grids and counterstained with 2% aqueous uranyl acetate for seven minutes 
and 1% aqueous lead citrate for two minutes. Observation was with a JEOL 1011 transmission 
electron microscope (Peabody, MA).  After TEM images were collected, they were formatted 
using Adobe Photoshop for brightness and contrast. In addition, during slide preparation, a silica 
particle could create stretching in the epon resin during the slicing sequence, and when stretching 
was severe, the silica particle could fall out of the resin. During TEM imaging, any areas where 
the silica particles fell out will show as bright white, causing difficulty in image focusing. These 
images were corrected by recoloring the white areas back to the color of the silica particles. 
Importantly, this may result in a slight increase in the silica particle size for the areas that were 
recolored. In the images at higher magnification, these areas are labeled. 
Statistics 
The results are presented as mean ± SD from at least three experiments, and statistical 
analyses were performed using the Student t-test or one-way ANOVA corrected for multiple 
comparisons using Prism software (version 7, GraphPad Software Inc). The statistical significance 
of differences was set at p<0.05. 
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3.3 Results 
3.3.1 Crystalline silica and low dose LPS enhance glycolysis without affecting macrophage 
viability 
To study the effect of silica on glycolysis, we utilized RAW 264.7 macrophages cell, which 
we have previously shown to release high concentrations of TNF-α and IL-1β in response to silica 
while experiencing low cytotoxicity to a wide range of concentrations of silica particles [78]. Using 
these macrophages, we show that both low dose LPS (1 ng/ml), that did not alter macrophage 
viability, as well as high dose concentrations (10 ng/ml), that induced a significant amount of cell 
necrosis with associated release of lactate dehydrogenase (LDH), were as effective as non-amounts 
of lactate in RAW 264.7 macrophages, over a period of 24h (Figure 20A). Addition of silica to 
low dose LPS-primed RAW 264.7 macrophages induced a significantly greater increase in the 
release of lactate compared to cells treated with LPS alone (Figures 20B).  
 
Figure 17 Lactate release from cells exposed to LPS or silica with or without priming with LPS 
 
Under these experimental conditions, RAW 264.7 macrophages exposed to silica or LPS 
alone experienced low levels of necrosis, and less than 30% of the cells exhibited propidium iodide 
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uptake 24h after exposure (Figure 21A-C). In contrast, the combination of silica and LPS induced 
significant necrosis, with 70% of the cells up taking propidium iodine 24h after exposure (Figure 
21A-C). In Figure 21C, it is illustrated the gating strategy to differentiate cells death by early 
apoptosis (Annexin V+PI-), late apoptosis (Annexin V+PI+) or necrosis (Annexin V-/PI+). Primed 
cells treated with silica showed a larger number of necrotic cells (Annexin V-/PI+), while in 
response to silica or LPS alone, the number of necrotic cell death was lower. Cell death due to 
apoptosis was very little or absent. **** p<0.0001 
 
 
Figure 18 Assessment of cell damage and cell death 
(A) LDH released from cells exposed to LPS or silica with or without priming. (B) Annexin V and Propidium 
iodide used to analyze cell survival by flow cytometry. (C) graph summarizing the survival of cells. 
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3.3.2 Silica remodels ETC-complexes activity 
In response to live bacteria, but not LPS, macrophages experience mitochondrial 
respiratory change adaptations that contribute to their antibacterial response [48]. These effects 
require the phagocytosis of bacteria into a phagosome are metabolically demanding and contribute 
to cytokine production [48]. Similar to bacteria, macrophages phagocytose silica particles into 
phagosomes and attract mitochondria to these organelles (Figure 22) [79]. Figure 22 displays 
transmission electron microscopy (TEM) images obtained from a RAW 264.7 macrophages, as a 
function of time, following silica (20 g/cm2) exposure. Images illustrate the incorporation of 
silica particles into phagosomes, 1h after exposure (A), and the subsequent recruitment of 
mitochondria to the silica-containing phagosomes 2h (B), 4h (C), and 6h (D) after silica exposures.   
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Figure 19 Macrophages recruit mitochondria to silica-containing phagosomes 
Using a high-resolution respirometer, we evaluated the effects of silica on mitochondrial 
respiration as well as the activity and integrity of the ETC in RAW 264.7 macrophages. To evaluate 
the contribution of CII in the respiration of silica-activated macrophages, LPS or silica-exposed 
RAW 264.7 macrophages were stimulated with succinate, the CII substrate, and the oxygen flux 
was subsequently recorded. RAW 264.7 macrophages (5x106/chamber) were allowed to 
equilibrate in the chamber for about 10 minutes prior to measuring oxygen flow. Default 
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respirometric settings of block temperature 37°C; stir bar speed 400 rpm, and data recording every 
2s were used.  
 
 
Figure 20 Assessment of Oxygen flux after stimulation of RAW 264.7 macrophages with succinate 
(A) Graph of oxygen flux. (B) Oxygen flux fold of increase. 
 
Figure 23A shows the oxygen turnover (oxygen concentration, left y-axis, oxygen flux, 
right y-axis) by treated RAW 264.7 macrophages cells followed at the equilibrium after the 
addition of succinate (final concentration 10 mM). Since the variation in oxygen concentration 
(broken traces) are difficult to appreciate because it is very little, the slope of the oxygen 
concentration is also shown (solid trace), which represents the negative derivative of the oxygen 
concentration. Variations in oxygen flux as fold increase were measured as a ratio between the 
value of the O2 slope at the equilibrium after treatment with succinate, and the value of O2 slope 
at the baseline.  
When healthy untreated cells were stimulated with succinate, the oxygen flux through the 
ETC physiologically increased (Figure 23A). This physiologic response, identified 2h after 
exposure, was significantly augmented in cells treated with silica and, although it peaked 6h after 
exposure when the oxygen flux increased threefold, it lasted for the 24 h experiment. In contrast, 
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RAW 264.7 macrophages exposed to LPS only showed a modest, although significant, and 
transitory, achieving maximal response by 6h, increase in mitochondrial respiration in response to 
succinate, even in the presence of silica (Figure 23B) 
To assess the production of ROS and oxygen consumption by CII in the forward direction 
(toward complex V, ATPase enzyme), we performed a substrate-uncoupler-inhibitor titration 
(SUIT) assay, wherein pre-treated RAW 264.7 macrophages were incubated with CI inhibitor 
(rotenone), before stimulation with CII substrate (succinate). (see Experimental section).  
 
Figure 21 Graph of oxygen flux in RAW 264.7 macrophages cells following a SUIT assay protocol 
 
Figure 24 shows the oxygen turnover (oxygen concentration, left y-axis, oxygen flux, right 
y-axis) by treated RAW 264.7 macrophages followed after addition of rotenone (final 
concentration, f.c. 0.5 µM), succinate (f.c. 10 mM), ADP (f.c. 2.5 mM), CCCP (f.c. 0.05 µM) and 
antimycin A (f.c. 2.5 µM). Variations in oxygen flux for each condition were measured as a ratio 
between the value of the O2 slope at the equilibrium after inhibition of complex I with rotenone 
and stimulation of complex II with succinate, and the value of O2 slope at the baseline. 
SUIT assay performed on resting cells showed a decrease in O2 flux after inhibition of CI, 
followed by a slight recovery of the O2 consumption and flux resulting from stimulation of CII 
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with succinate. Subsequently, the uncoupler increased the O2 slope above the baseline, while 
antimycin A, blocking CIII, cytochrome c reductase, suppressed the mitochondrial respiration 
(Figure 24).  
 
Figure 22 Oxygen flux after the inhibition of CI with rotenone and stimulation of CII with succinate 
 
The sequential treatment of silica exposed RAW 264.7 macrophages with CI inhibitor and 
CII substrate confirmed the aforementioned synergistic effect of silica on the enzymatic effect of 
CII as these cells exhibited a significant time-dependent increase of O2 consumption, that, although 
identified at 2h, it peaked at 6h exposure, proving a substantial rise in respiration only through 
complex II (Figure 25). In contrast, cells exposed to LPS showed transitory enhancement on 
mitochondrial respiration and was only identified 4h after treatment (Figure 25). Similarly, 
priming with LPS before silica did not alter the O2 flux over 24h (Figure 25).  
The integrity of the mitochondrial membrane was also assessed by the addition of the 
uncoupler (Figure 26A). Silica itself did not uncouple the ETC even in the presence of priming, 
as shown by the increase of O2 flux after the addition of CCCP (Figure 26C, D). In contrast, LPS 
markedly damaged the mitochondrial membrane, as shown by the absence of alteration in the O2 
curve after the addition of CCCP (Figure 26B).  
 62 
 
Figure 23. Graph of Oxygen flux following SUIT assay in different condition 
 
Subsequently, we then examined the CII-mediated production of hydrogen peroxide 
(H2O2) by Amplex Red while subjecting the RAW 264.7 macrophages to the SUIT assay protocol.  
 
Figure 24 Graph of Amplex Red flux following a SUIT assay protocol 
Figure 27 shows the production of H2O2 assessed following the slope (purple trace) of the 
concentration of the fluorescent Amplex Red assay product resorufin (green trace) while 
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performing a SUIT assay protocol (see Experimental section). Variations in H2O2 for each 
condition were measured as the ratio between the value of the slope at the equilibrium after the 
inhibition of CI with rotenone and the stimulation of CII with succinate, and the slope at the 
equilibrium at the baseline.  
CI inhibition, followed by CII stimulation in resting RAW 264.7 macrophages, caused an 
immediate increment of H2O2 generation, similar to the one observed above during the proton leak 
state. Addition of ADP, inducing CII-linked oxidative phosphorylation (OXPHOS), reduced H2O2 
production. Furthermore, the uncoupling of the system rebooted the production of H2O2 that was 
ultimately suppressed by CIII inhibition (Figure 27). 
 
Figure 25 Fold increases H2O2 production after the addition of rotenone and succinate 
 
Compared to LPS treated cells, silica exposed RAW 264.7 macrophages showed 
significantly higher production of H2O2 6h after silica exposure, confirming the increased O2 
consumption through CII (Figure 28). These findings suggest that silica itself acts within the 
cells to enhance the activity of mitochondria complex II. 
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3.3.3 Silica inhibits CI activity in part by reducing ECSIT expression 
In addition to the high-resolution respirometry, we measured, via the enzymatic assays, the 
individual activity of CI and CII of silica exposed RAW 264.7 macrophages. Previously, we have 
shown that in RAW 264.7 macrophages, silica induces a time-dependent decrease in the expression 
of 39-kDa CI subunit, and subsequently, CI enzymatic activity was downregulated [78].  
Mitochondria pellets were isolated from RAW 264.7 macrophages, and complex I and 
complex II enzymatic activity were measured spectrophotometrically and measured as 
mAbs/min/μg proteins. In agreement with our previous data, we found that silica downregulates 
CI activity significantly in a time-dependent fashion with a lower activity after 6h exposure, while 
the non-toxic concentration of LPS (1ng/ml) did not interfere with the enzyme function of this 
mitochondrial complex (Figure 29).  
 
Figure 26 Measurement of Complex I activity 
 
Conversely, CII activity was significantly enhanced by silica alone in a time-dependent 
manner, with the most significant increase in enzymatic activity observed 6h after exposure 
(Figure 30). In contrast, LPS weakly stimulated the enzyme’s activity at 4-6h exposure. (Figure 
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30). These findings reproduced the results of the respirometric assay, confirming a crucial role of 
CII in the mitochondrial response of macrophages to silica. 
 
Figure 27 Measurement of Complex II activity 
 
CI is the largest of the five ETC complexes in the mitochondrial membrane; it consists of 
44 core and accessory subunits [83-85]. Among the 14 factors involved in this assembly process, 
Evolutionarily Conserved Signaling Intermediate In Toll Pathway (Ecsit) has a crucial role in the 
regulation of the stability and activity of the CI and subsequently the mitochondrial function [86]. 
To understand the mechanism that drives the decreased enzymatic activity of CI in silica-exposed 
RAW 264.7 macrophages, we studied the expression of Ecsit in the mitochondria of silica-exposed 
cells. Ecsit (37 kDa subunit) abundance was determined by western blot while using Complex IV 
subunit MTCO1 as markers for mitochondria and GAPDH expression as a loading control. 
Mitochondrial protein derived from silica-exposed cells showed a time-dependent decreased 
abundance of Ecsit 6h after silica exposure (Figure 31). 
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Figure 28 ECSIT abundance determined by Western Blot 
 
This finding was confirmed by direct visualization of the protein using 
immunofluorescence, wherein cells treated with silica with or without LPS priming exhibit a 
significantly decreased content of Ecsit overtime with a peak after 4 hours exposure (Figure 32). 
In contrast, cells treated with LPS did not show a substantial decrease in Ecsit protein and 
demonstrated persistent expression of Ecsit (Figure 32). In figure 32, mitochondria are visualized 
by staining with ATPase (red), DNA into the nuclei of cells with DAPI (4′,6-diamidino-2-
phenylindole), followed by the analysis of Ecsit (green). Scale bar 10 microns. 
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Figure 29 Ecsit protein visualized at confocal microscopy in RAW 264.7 macrophages 
3.3.4 The importance of mitochondrial Complex II activity on macrophage survival to 
silica 
Macrophages differ significantly in their response to silica, and previously we reported that 
the RAW 264.7 and IC-21 macrophages cell lines, which reproduce the effects of silica on primary 
mouse macrophages derived from BALB/c and C57BL/6J mice respectively [81, 87], differ 
significantly in their viability and cytokine response to silica [78]. Thus, while RAW 264.7 
macrophages release TNF-α and exhibit a low rate of cell cytotoxicity in response to silica, S 
macrophages do not release TNF-α and experience universal cell death, even at low concentrations 
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of silica particles [78]. Therefore, to better understand the role of mitochondrial complex II on 
macrophage survival, we compared the effect of silica particles on the enzymatic activity of 
complex II on RAW 264.7 and IC-21 macrophages.  
Our studies on cell viability demonstrated that while silica-induced significant cell 
cytotoxicity and LDH release in IC-21 macrophages, LPS does not impact these parameters 6-24 
hours after exposure (Figure 33A, B). Importantly, the addition of silica to IC-21 macrophages 
primed with a non-toxic concentration of LPS resulted in a synergistic effect that reduced the cell 
survival to 5% at 24h post-exposure (Figure 33A, B).  
 
 
 
Figure 30 Graph summarizing the survival of IC-21 macrophages treated as above 
(A) Annexin and PI staining, (B) LDH release. 
 
Under these experimental conditions, LPS-stimulated IC-21 macrophages enhanced the 
release of lactate to a greater extent than IC-21 macrophages exposed to silica (Figure 34).  
 69 
 
Figure 31 Lactate released in the supernatant from IC-21 macrophages 
 
Figure 35 shows the respirometric analysis on IC-21 macrophages, illustrated as fold 
increase of oxygen flux after stimulation with succinate (A), or after the inhibition of CI with 
rotenone and stimulation of CII with succinate (B), and fold increase of the production of H2O2 
after rotenone-succinate (C).  
In contrast to the data described above for RAW 264.7 macrophages, stimulation of CII 
with succinate, in the presence or absence of rotenone-inhibition of CI, does not affect the oxygen 
flux, nor the ROS production in LPS treated IC-21 macrophages (Figure 35A-C). In contrast to 
LPS, silica particles induced significant increases in the oxygen flux and ROS production in IC-
21 macrophages (Figure 35A-C), suggesting that the enzymatic activity of CI was not affected by 
silica exposure on IC-21 macrophages (Figure 36A). Conversely, CII activity was significantly 
inhibited in IC-21 by silica alone as early as 2 hours post-exposure, even after LPS priming (Figure 
36B)  
 70 
 
Figure 32 Respirometric analysis in IC-21 macrophages  
 
 
 
Figure 33 Measurement of CI and CII enzymatic activity in IC-21 macrophages 
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3.3.5 Silica and LPS exert similar effects on glucose uptake and glycolysis but differ on the 
effects on the TCA cycle in macrophages 
LPS-stimulation of macrophages leads to perturbations of glycolysis and TCA cycle that 
contribute to cytokine specification [47, 88-92]. To investigate the effects of silica on glucose 
metabolism and the TCA cycle activity of RAW 264.7 macrophages, we fed cells with 13C6-
glucose, and conducted a stable isotope tracer analysis using high-resolution mass spectrometry to 
discern subtle shifts in energy substrate metabolism, through the detection and quantification of 
metabolite isotopologues from control, non-cytotoxic dose of silica (50 μg/cm2), or LPS (10 ng/ml) 
exposed macrophages (Figure 37 and Appendix B).  
In figure 37 is represented a summary of metabolic changes in RAW 264.7 macrophages 
exposed to silica. The arrows indicate increases or decreases of metabolite normalized on control. 
(IDH, isocitrate dehydrogenase. SDH, succinate dehydrogenase) 
 
Figure 34 Schematic of metabolic changes in RAW 264.7 macrophages exposed to silica 
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Our LC-MS analysis revealed that when compared to control cells, both LPS, as well as 
silica, induce an increase in the uptake and phosphorylation of glucose, as illustrated by 
intracellular enrichment in glucose-6-phosphate and glyceraldehyde-3-phosphate (Figure 38 A-
C). 
 
Figure 35 Intracellular total amount of hexose uptake and glycolytic metabolites glucose-6-phosphate and 
glyceraldehyde-3-phosphate 
 
Isotopologues analysis shows that compared to control cells, both silica-, as well as LPS-
exposed RAW 264.7 macrophages exhibit higher, but comparable, enrichment in intracellular 
levels of pyruvate and lactate (Figure 39A-C). [Atomic percent enrichment calculated using the 
Mass isotopomer multi-ordinate spectral analysis (MIMOSA) method.] 
 
Figure 36 13C6 uptake and intracellular pyruvate and lactate enrichment determined by LC-HRMS  
 
However, LPS treated RAW 264.7 macrophages demonstrate a higher ratio (0.38) of 
conversion of pyruvate into lactate when compared to control (0.29) or silica exposed (0.33) 
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macrophages (Figure 20A and Table 1) leading to a greater intracellular and extracellular 
enrichment in lactate (Figure 40). 
 
Table 1 Rate of conversion measured as a ratio between the sum of enrichment(M+1 to M+6) of 2 metabolites 
 
 
 
Figure 37 Changes in lactate intracellular atomic percent enrichment 
 
Compared to control or silica-treated RAW 264.7 macrophages, LPS induces intracellular 
enrichment of the TCA cycle intermediates glutamine, succinate, fumarate, malate, and itaconate 
while maintaining the levels of citrate, alpha-ketoglutarate, and glutamate (Figure 41A-H). In 
addition, LPS-stimulated cells show enrichment on amino acids, glutamine, proline, arginine, 
derived from these intermediates (Figure 41G, I, L). In contrast to control or LPS-exposed 
macrophages, intracellular levels of citrate are not detectable in silica-exposed macrophages 
(Figure 41A), and these silica-exposed macrophages exhibit significant reduction, compared to 
control or LPS-stimulated cells, in the intracellular enrichment of alpha-ketoglutarate, itaconate, 
succinate, fumarate, malate, glutamine, and glutamate (Figure 41A-H). 
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Our data show that both LPS, as well as silica, influence the enzymatic activity of SDH, an 
enzyme that plays a fundamental role in both glycolysis and ETC (Figure 25 and 30).  Glutamine-
dependent anaplerosis is the principal source of succinate, although the ‘GABA (γ-aminobutyric 
acid) shunt’ pathway also has a role in LPS-stimulated macrophages. Therefore, we measured the 
rate of conversion of glutamate into succinate (Table 1). LPS treated macrophages show increased 
rates (0.59) of glutamate conversion to succinate. This conversion rate was not significantly altered 
by silica, and isotopologues analysis showed that while the baseline glutamate enrichment was 
comparable among control, LPS-, or silica- treated cells (M+0 to M+4); a higher enrichment of 
succinate was detected at M+2 only in LPS-exposed macrophages (Figure 6M, N).  
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Figure 38 (A-L) Intracellular total amount of TCA cycle 
(A-F) metabolites and (G-L) aminoacids. (M, N) Changes in succinate and glutamate atomic percent 
enrichment. 
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3.3.6 LPS, but not silica exposure, induces stabilization of HIF-1α, activation of caspase 1, 
and release of IL-1β 
As we described in the introduction, LPS-stimulated macrophages exhibit altered 
intracellular metabolic changes that specify immune effector mechanisms such as cytokine 
secretion. To determine whether these changes also take place in silica exposed macrophages we 
correlated the metabolic changes observed in RAW 264.7 macrophages in response to silica with 
the production of IL-1β, TNF-α, and INF-β, three cytokines that have been implicated on the 
pathogenesis of silicosis [23]. In bone marrow-derived macrophages LPS enhances succinate 
levels, leading to succinate-mediated stabilization of HIF-1α, activation of NLRP3 inflammasome, 
and IL-1β production [46, 47, 93, 94]. In this work, we find that in contrast to LPS, silica reduced 
the intracellular levels of succinate below the baseline levels observed in unstimulated RAW 264.7 
macrophages (Figure 41D). To assess the correlation between the SDH activity, the level of 
succinate, and expression of HIF-1α, we stimulated RAW 264.7 macrophages with silica for 6 
hours, with or without priming with LPS (1 ng/ml for 24h). Giving the well-known sensitivity of 
HIF-1α gene to oxygen tension, we documented the ability of silica or LPS to stabilize HIF-1α 
expression under either normoxic (O2=20%) or hypoxic (O2 less than 5%) conditions. Silica, as 
well as LPS, promoted the time related, stabilization of HIF-1α protein under normoxic conditions 
as demonstrated via immunoblotting (Figure 42A upper panel), and confirmed by 
immunofluorescence. (Figure 42B).  
However, these changes on HIF-1α protein expression, that were accentuated by hypoxia, 
were associated with activation of the NLRP3 inflammasome, documented by the cleavage of the 
pro-caspase 1 into low molecular weight (p10) mature caspase 1, and the fragmentation and release 
of IL-1β only in LPS-stimulated RAW 264.7 macrophages (Figure 42A middle panel).  
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Figure 41 A illustrates HIF-1α (110 kDa subunit) abundance, Pro-Caspase 1, Caspase 1 
(10 kDa), and IL-1β (37 kDa) determined by western blot while using β-actin expression as a 
loading control, from proteins isolated from RAW 264.7 macrophages and exposed as described. 
Figure 41B represents confocal microscopy of RAW 264.7 macrophages stimulated for 6 hours 
with LPS (1 ng/ml) or Silica (50 μg/cm2) in the presence or absence of priming. DNA into the 
nuclei of cells is visualized with DAPI (4′,6-diamidino-2-phenylindole), followed by the analysis 
of HIF-1α (red). Scale bar 10 microns. 
 
Figure 39 HIF-1α (110 kDa subunit), Pro-Caspase 1, Caspase 1 (10 kDa), and IL-1β (37 kDa) abundance 
determined by western blot and immunofluorescence 
 
Yet, silica-stimulated RAW 264.7 macrophages demonstrated enhanced IL-1β mRNA and 
release of IL-1β peptide in culture in the absence of pro-caspase 1 activation (Figure 43A, B) 
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suggesting that silica-induced IL-1β production could take place independent of succinate 
associated-HIF-1α mediated NLRP3 inflammasome activation. 
 
 
Figure 40 Measurement of IL-1 β expression and release 
(A) IL-1β mRNA expression quantified by RT–PCR. (B) ELISA of IL-1β released in the supernatant. 
3.3.7 Malonylation of GAPDH correlates with TNF-α production in LPS, but not in silica 
exposed macrophages  
The citrate-derived metabolite malonyl CoA induces the malonylation of multiples 
proteins, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), specifically on Lysine 
213. In resting cells, GAPDH sequesters the TNF-α mRNA, blocking its translation. Upon LPS 
stimulation, GAPDH undergoes malonylation, a reaction that facilitates the release of TNF-α 
mRNA for transcription and subsequent secretion [95]. In our study, we find that LPS, as well as 
silica, stimulated macrophages release TNF-α in a dose-dependent manner (Figure 44A) 
Compared to non-stimulated RAW 264.7 macrophages, silica, as well as LPS, enhanced GAPDH 
and TNF-α mRNA expression (Figure 44B).  
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Figure 41 Assessment of TNF-α expression and release 
(A) Cell supernatants examined for TNF-α secretion using ELISA. (B) TNF-α and GAPDH mRNA expression 
levels quantified by RT–PCR. 
 
However, immunoprecipitation of GAPDH from protein lysates obtained from silica or 
LPS-stimulated RAW 264.7 macrophages identified GAPDH malonylation, in a manner that 
proceeded TNF-α release, exclusively in LPS exposed macrophages (Figure 45). 
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Figure 42. Samples probed with an anti-malonyl lysine (anti malk) and  GAPDH expression in the 
immunoprecipitated (upper panel) samples  
3.3.8 Decreased itaconate levels correlate with decreased IFN-β in silica-exposed 
macrophages 
The anti-inflammatory features of the TCA metabolite itaconate have been described in 
LPS treated macrophages. Endogenous itaconate regulates succinate levels and limits IL-1β 
production in LPS-activated macrophages [96, 97]. Our data show that LPS-activated RAW 264.7 
macrophages increase the intracellular amount of itaconate, while silica-activated macrophages 
reduce the concentrations of this TCA intermediate below control levels (Figure 41B). Thus, LPS 
(10 ng/ml) stimulates the transcription of IFN-β in macrophages, while silica reduces the 
transcription and release of this mediator over a 24 h period (Figure 46A). Addition of silica to 
LPS-primed RAW 264.7 macrophages restores the ability of RAW 264.7 macrophages to release 
IFN-β in a synergistic manner (Figure 46B). 
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Figure 43 Assessment of IFN--β expression and release 
 (A) IFN--β mRNA expression levels quantified by RT–PCR. (B) Cell supernatants examined for IFN-β 
secretion using ELISA. 
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4.0 Discussion 
The main finding of the current work is that in contrast to the prevalent view, respirable, 
sterile, crystalline silica alone is capable of inducing an innate immune response without requiring 
previous macrophage activation by LPS.  This silica-induced activation of macrophages is 
different from the LPS-induced since they affect differently the CII of ETC, which plays a crucial 
role in macrophages survival and silica-induced inflammatory response.  
In contrast to LPS, very little data are available regarding the metabolic reprogramming of 
macrophages in the silica-induced inflammation and subsequent development of silicosis. The 
purpose of our study is to elucidate critical aspects of silica-induced fibrotic inflammation, 
comparing the metabolic effect of low dose LPS, to silica with or without priming with LPS.  
LPS-activated macrophages switch their metabolism from OXPHOS to aerobic glycolysis,  
“Warburg effect” [45], which consists of increased uptake of glucose, glycolysis rate and 
subsequent secretion of lactate, in conjunction with a reduced level of OXPHOS via the TCA cycle 
[47]. In our study, we found that non-toxic concentration of LPS, as well as silica, induce increased 
uptake of hexoses, increased concentration of intracellular glycolytic metabolites, and augmented 
absolute amount of intra- and extracellular lactate.  Moreover, priming of macrophages with LPS 
before silica exposure enhanced cytotoxicity and the observed effect of LPS alone.  
In a recent study, Garaude et al. reported that following phagocytosis of live bacteria by 
bone marrow-derived macrophages (BMDM) showed alterations in the assembly of the ETC 
super-complexes, consisting of reduced CI activity, and enhanced CII abundance and activity [48]. 
These findings were not observed when BMDM were stimulated with LPS [48]. Consistent with 
this work, our study demonstrates that shortly after macrophage engulfs silica particles, 
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phagosomes are formed and recruit mitochondria (Supplemental Figure 1). Concomitant to these 
ultrastructural findings, silica exposed macrophages remodel the activity of ETC and increase 
mitochondrial oxygen flux through CII, 2 h post-exposure, even after the inhibition of CI with 
rotenone (Figure 2). In contrast to silica, LPS only induces a transitory enhancement on 
mitochondrial respiration in the absence of mitochondrial CI inhibition by rotenone (Figure 2). 
The measurement of mitochondrial ROS production also revealed that silica engulfment is more 
efficient than LPS in the induction of mitochondrial H2O2 release from the activated macrophages. 
Priming of macrophages with LPS before silica treatment did not enhance the effect of silica on 
CII, nor the production of mitochondrial ROS (Figure 2).  The analysis of the kinetic enzymatic 
activity of CI and CII also confirmed that while LPS did not alter CI activity, it only slightly 
enhanced CII activity, 4-6 h post-exposure, in contrast to silica that significantly decreased CI 
activity while simultaneously enhancing CII activity (Figure 3).  
The most commonly observed CI dysfunctions are explained by alterations in CI subunits 
critical for its assembly.  Ecsit is a CI subunit that plays a critical role in both the CI assembly 
stability and the metabolic activity of the complex in macrophages [84, 86, 98].  This confers an 
essential role for Ecsit in the antibacterial response of macrophages, due to its involvement in the 
recruitment of mitochondria around the site of intracellular bacteria [99], and its regulation of 
mitochondrial ROS production from the ETC [86].  In our study, the downregulation of Ecsit 
occurs in silica-, but not in LPS, exposed macrophages in a time-dependent manner, supporting 
the notion that this protein plays an essential role in the modulation of CI activity in response to 
silica.  
IC21 macrophages, that we previously demonstrated generate more significant amounts of 
mitochondrial ROS, experience higher levels of cell death, and secrete lower amounts of TNF-α 
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than RAW 264.7 macrophages in response to silica [78], we further show evidence supporting the 
notion that in the absence of a functional CI, the enhanced activity of mitochondrial CII is 
fundamental to preserve mitochondrial respiration and the survival of macrophages in response to 
silica. Thus, in IC21 macrophages CI activity is preserved (Figure 4), and in contrast to RAW 
264.7 macrophages, silica exposure rapidly diminishes, as early as 2h, the enzymatic activity of 
mitochondrial CII (Figure 4) and oxygen flux proceeds via mitochondrial CI activity leading to 
higher amounts of mitochondrial ROS generation that we previously show contributes to 
cardiolipin oxidation and cell death [78] 
Our data also support the concept that although both LPS, as well as silica, stimulates 
aerobic glycolysis, they affect the TCA cycle in a different manner. An important difference 
observed between LPS- and silica-stimulated macrophages in the activity of the TCA cycle is the 
accumulation of succinate, which acts as a potent pro-inflammatory signal [46, 47]. LPS-induced 
increases in succinate can be explained by several mechanisms, including the inhibition of SDH 
by itaconate, as well as replenishment of succinate from glutamine through the anaplerosis by 
alpha-ketoglutarate, or through the GABA shunt [47].  In contrast, silica induces an overall 
intracellular depletion of TCA metabolites and amino acids, including succinate, alpha-
ketoglutarate, fumarate, glutamine, glutamate (Figures 5 and 6).  These data suggest that in contrast 
to LPS, silica enhances the enzymatic activity of mitochondrial CII, demonstrated here as 
enhanced CII-mediated mitochondrial respiratory, in the absence of a functional CI (Figure 2).  
This CII activity enhances TCA dynamics with consumption, rather than accumulation, of 
succinate.  Similarly, our data show that silica does not enhance the conversion of glutamate into 
succinate observed in LPS exposed macrophages (Figure 5). 
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Activated macrophages exhibit altered metabolism that governs immune effector 
mechanisms such as cytokine secretion.  Similar to LPS, silica treated RAW 264.7 macrophages 
release TNF-α and IL-1β in a dose-dependent manner (Figures 7 & 8).  However, studies in LPS-
stimulated macrophages show that these metabolic changes contribute to the production of TNF-
α and IL-1β by different mechanisms leading to cytokine specification [47].  Thus, inhibiting 
glycolysis or blocking SDH in LPS-stimulated macrophages inhibits IL-1β, but not TNF-α, 
production [47].  In macrophages, succinate is an inflammatory signal that contributes to the 
activation of NLRP3 inflammasome [46, 94].  These effects, described in LPS-stimulated 
macrophages, are mediated via the stabilization of HIF-1α that subsequently induces transcription 
of HIF-1α target genes such as IL-1β [46, 47, 93, 94].  In the current work, we find that silica-
stimulated RAW 264.7 macrophages demonstrate stabilization of HIF-1α, and enhanced 
transcription and release of IL-1β (Figure 7).  However, in contrast to LPS, these silica-induced 
changes occur in the presence of decreased levels of intracellular succinate (figure 6) and are 
unrelated to NLRP3 inflammasome activation as these RAW 264.7 macrophages do not show 
caspase1 activation in response to silica particles alone (Figure 7).  Importantly, previous reports 
demonstrating the ability of silica to activate the NLRP3 inflammasome were conducted in LPS-
primed macrophages [19, 20, 23]. 
The role of TNF-α in the pathogenesis of silicosis is well recognized [24].  However, the 
mechanisms specifying TNF-α production by silica exposed macrophages are not entirely 
understood.  Recent information shows that macrophages secretion of TNF-α and interferons in 
response to LPS is mediated, in part, via malonylation of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) [95, 100, 101].  White et al. identified a role for GAPDH as a 
noncanonical RNA-binding protein [102]. In resting macrophages, GAPDH binds to and 
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suppresses the translation of inflammatory mRNAs, including IFN and TNF-α [102].  GAPDH 
binds NAD+ to retain mRNAs silent.  LPS-induced malonylation of GAPDH requires the 
separation of NAD+ from the enzymatic domain to facilitate protein malonylation on lysine 213 
[95]. However, in this work, we only documented lysine 213 malonylation on protein precipitates 
from LPS exposed RAW 264.7 macrophages, in a manner that precedes the transcription and 
release of TNF-α (figure 8). These data agree with previous observations linking the silica-induced 
TNF-α generation to NADPH- and mitochondrial ROS mediated NF-κB activation and TNF-α 
mRNA transcription [99, 103, 104]. 
The anti-inflammatory properties of itaconate, a TCA cycle metabolite generated through 
the decarboxylation of cis-aconitate, a product of citrate, have also been described in LPS-activated 
macrophages [105]. LPS-induced accumulation of itaconate, mainly due to the isocitrate 
dehydrogenase impairment, inhibits SDH, thereby decreasing the inflammatory response, and also 
regulate the IFN-β secretion [97, 106]. In this study, we observed that, while the intracellular level 
of itaconate is significantly augmented in LPS-activated macrophages, the same does not occur 
after silica engulfment, and consequently this directly correlates with the transcription and release 
of interferon-beta (IFN-β) in response to either LPS or silica (figure 8).  
In summary, the present work indicates that upon internalization into phagolysosomes, 
respirable crystalline silica drives a metabolic adaptation of macrophages consisting of increased 
uptake of glucose, increased glycolysis rate, accompanied by an increased lactate secretion, at the 
expense of the OXPHOS, which becomes sustained only by an increased CII activity, while CI 
activity is reduced (Figure 44). Given the role of CII as a component of both the TCA cycle and 
the ETC, its activity becomes a key regulator of macrophages' survival.  Silica also modulates the 
TCA cycle, where not only the succinate level is measured below baseline, but also the total 
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intracellular level of all key TCA cycle intermediates and amino acids examined are decreased 
probably as a result of high demand and consumption. In contrast to LPS, these silica-induced 
metabolic adaptations do not correlate with IL-1β, TNF-α, production but with the suppressed 
release of IFN-β. Further studies are needed to validate this concept and to understand better the 
mechanisms that induce the release of inflammatory cytokines after the phagocytosis of silica into 
macrophages.  
 
Figure 44 Graphical summary 
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5.0 Conclusions 
Exposure of workers to crystalline silica in the US and worldwide has resulted in extensive 
disease and continues to be an occupational hazard for millions of workers [107, 108]. Although 
preventive measures have decreased the mortality attributable to silica-related lung disease, a large 
number of silica-exposed patients are still dying [68, 109]. Moreover, the public health concern is 
also raised due to the evidence that silica is a potent risk factor (4 times) for the development of 
tuberculosis among exposed miners and stone crushers [4, 13, 14]. Thus, even if preventable, 
silicosis remains a disease without specific and effective treatment available, including lung 
transplant [66, 70]. Therefore, understanding the pathogenic mechanisms of silicosis is essential 
to identify targets that predict individual susceptibility or provide a window of opportunity for 
therapeutic intervention.  
Gulumian et al. identified CCSP, the main secreted product of Club cells, as a possible 
biomarker of silica-induced lung disease [71]: in healthy subjects, CCSP concentration in the BAL 
is between 1-2 mg/l [49], at the surface of the airways has been estimated at 100 mg/l [49], while 
serum CCSP levels are in the range of 10-15 μg/l [73]. Interestingly, a significant reduction of 
serum CCSP and lung CCSP mRNA was found in asymptomatic silica-exposed workers [43], as 
well as in patients suffering for sarcoidosis, asthma, and pulmonary fibrosis [49]. 
Nonetheless, it is still unclear the mechanisms by which silica alters the CCSP expression 
in the lung and the subsequent role that this altered CCSP expression plays in the pathogenesis of 
silicosis. Club cells might be directly damaged by silica or indirectly, secondary to lesions of other 
cell types within the respiratory epithelium, which are sensitive to lung irritants, or by cytotoxic 
mediators released from activated macrophages that have engulfed silica particles [43]. 
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Macrophages are indeed the only immune cells involved in the removal of silica particles 
from the lung, and on their ability depends the development of the disease. Following the 
deposition of silica particles in the distal lung, resident macrophages mobilize to the site of 
particles and phagocytose them. The activation of the NLRP3 inflammasome is recognized as the 
principal mediator of the silica-induced inflammation [19, 20, 23, 44]. In LPS-activated 
macrophages, the metabolic switch from mitochondrial respiration to glycolysis (“Warburg effect” 
of aerobic glycolysis), and accumulation of succinate [45, 47] lead to the activation of NLRP3 and 
subsequent transcription and release of many inflammatory cytokines [46, 47, 89, 90, 92-95, 100]. 
In contrast, very little data are available regarding the metabolic reprogramming of macrophages 
in the silica-induced inflammation and subsequent development of silicosis. 
In the absence of consistent data on the cellular and molecular mechanisms that regulate 
the innate immune response and its relevance to the regenerative program of the conductive lung 
epithelium, it is complicated to find a therapeutic strategy for this disease. In an attempt to fill the 
gaps in the literature, this dissertation describes:  
1) the silica-related damage of conducting epithelium at the BADJ, represented by 
disorganization of Club cells, decreased proliferation of Club cells progenitor cells, and reduced 
CCSP content, which leads to increased TLR responses and of TNF-α release from alveolar 
macrophage activated in response to silica;  
3) The nature of the metabolic response induced by silica in macrophages, and its 
contribution to cytokine specification, and the pathogenesis of silicosis. Internalization into 
phagolysosomes of respirable crystalline silica, in the absence of LPS, drives a metabolic 
adaptation of macrophage consisting of increased glycolysis, decreased mitochondrial respiration, 
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sustained only by CII, which becomes critical for cell survival, and it’s associated to the release of 
inflammatory cytokines IL-1β, TNF-α, IFN-β.  
5.1.1 Silica-induced damage of Club Cells alters the BADJ, compromising the regenerative 
capacity while eliciting macrophage activation 
In this study, we provide evidence that silica causes progressive inflammation and 
remodeling of the small airways of the mouse lung, due to recruitment and accumulation of 
inflammatory cells and promotion of fibrosis (deposition of collagen and hydroxyproline) in the 
peribronchiolar and perivascular regions substantially at the terminal bronchial region (BADJ). 
This process compromises the proliferation of Club cells, which retain the capacity to regenerate 
both secretory and ciliated epithelial cell types during a fibrotic injury in mice.  
These effect of silica are associated with noticeable disorganization of CCSP 
immunoreactive cells and reduced CCSP content: because of the direct cell damage and death, 
Club cells enhances the release of CCSP protein into the luminal surface of the epithelium, 
resulting in higher CCSP protein levels into BAL concomitantly to a persistent inhibition in the 
total lung CCSP mRNA expression, already 3 d after silica exposure.  
Our findings also indicate that silica compromises the ability of CCSP expressing cells to 
proliferate: exposure of mice to silica results in epithelial disorganization in the absence of 
epithelial proliferation, as opposed to naphthalene, which resulted in depletion of CCSP cells in 
the presence of naphthalene-resistant stem cell proliferation. That signifies an impairment of the 
reparative capacity of epithelial cells within terminal bronchioles due to the silica damage. 
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These processes take place alongside with the establishment of adaptation in lung immune 
responses that include significant changes in the number of silica-laden macrophages recovered 
by BAL from these mice.  
Previous reports indicate that Club cells function in an anti-inflammatory capacity, and 
CCSP-/- mice mount an exacerbated inflammatory response to infectious or environmental agents 
[53, 60]. Consistent with an anti-inflammatory role for CCSP in the pathogenesis of silicosis, this 
study provides evidence that CCSP-/- mice exposed to silica, exhibit early recruitment of PMN 
and macrophages in the BAL, and enhanced early TNF-α expression in BAL, correlated with 
prominent expression of genes of TLR7 and 9 specifically in CCSP-/- macrophages located in 
areas of inflammation surrounding the terminal bronchioles. Shortly after phagocytosis of silica 
particles, CCSP-/- macrophages exhibit increased expression of TLR7 and 9, followed by rapid 
secretion of type Iα, but not type Iβ, interferon, and TNF-α. 
Altogether, these data support the possibility that CCSP levels in serum and respiratory 
secretions may constitute a valid biomarker to determine enhanced susceptibility to inflammatory 
responses to silica. Secondarily, the initial alteration responsible for the increased reactivity to 
silica could be related to the intracellular handling of silica by the macrophages rather than cell 
surface events.  
5.1.2 Immune metabolic response of macrophages to silica 
In this study, we demonstrate that in contrast to the prevalent view, respirable crystalline 
silica alone is capable of stimulating an innate immune response without requiring previous 
macrophage activation with LPS, and yet different from the one LPS-induced, since they affect 
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differently the CII of ETC, which plays a crucial role in macrophage survival and silica-induced 
inflammatory response. 
Using RAW 264.7 macrophages cell lines, we demonstrate that upon internalization into 
phagolysosomes, respirable crystalline silica drives a metabolic adaptation of macrophage 
consisting of increased uptake of glucose, increased glycolysis, accompanied by an increased 
lactate secretion, at the expense of the mitochondrial respiration. This process is also known as the 
“Warburg effect” of aerobic glycolysis in LPS-activated macrophages. [45, 110].  
The study of the mitochondria respiration and kinetic enzymatic activity of CI and CII 
demonstrate that in silica-activated macrophages, the ETC becomes sustained only by an increased 
CII activity, while CI activity is reduced, due to the direct impact of silica on Ecsit protein. Given 
the role of CII (succinate dehydrogenase) as a component of both the TCA cycle and the ETC, its 
activity becomes a key regulator of macrophages' survival.  
The use of IC-21 macrophages has generated more evidence on the crucial role played by 
CII in the immune response and macrophages survival in response to silica. Previously we reported 
that IC-21 macrophages treated with silica do not release IL-1β, nor TNF-α, while LPS priming 
enhanced the release of inflammatory cytokines [72]. Through the study of viability and 
mitochondrial respiration, we proved that in the absence of a functional CI, the enhanced activity 
of CII is fundamental to preserve mitochondrial respiration and the survival of macrophages in 
response to silica.  
Affecting CII, silica also modulates the TCA cycle, where not only the succinate level is 
decreased at 6h compared to control-treated cells, but also the total intracellular level of all key 
TCA cycle intermediates and amino acids examined (i.e., itaconate, glutamine, glutamate) are 
decreased at the same timepoint, probably as a result of high demand and consumption. In contrast 
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to LPS, these silica-induced metabolic adaptations do not correlate with IL-1β, TNF-α, production 
but with the suppressed release of IFN-β.  
5.1.3 Future directions 
The first line of defense against crystalline silica in the human lungs is represented by 
alveolar macrophages, whose unique function is to clear the lung of inhaled debris. According to 
the current literature, after the internalization of silica particles into macrophages, they become 
activated, following a process that requires the interaction between LPS and TLR4 initially. [19, 
23, 44]TLRs are a class of pattern recognition receptors (PRRs) that play a fundamental role in the 
innate immune response because they recognize bacterial or viral pathogen-associated molecular 
patterns (PAMPs) and activate a cascade of event that leads to the secretion of inflammatory 
cytokines [111-113]. TLR, however, are classified as plasma membrane receptors, including 
TLR1, TLR2, TLR4, TLR5, TLR6, and TLR10 [112, 114], and endosomal receptor, including 
TLR3, TLR7, TLR8, and TLR9 [113, 115].  Based on this evidence, in our study, we have analyzed 
10 TLR transcripts in mice and humans, and in contrast with the current literature, we found that 
CCSP-/- mice reported higher expression of TLR7 and TLR9 immunoreactivity was in 
macrophages located in areas of inflammation surrounding the terminal bronchioles.  
While TLR9 is essential for recognition of bacterial DNA through the presence of 
unmethylated CpG motifs [116], TLR 7 recognizes purine-rich single-stranded ribonucleic acid 
(ssRNA) [113]. Previous studies reported that TLR9 could recognize mitochondrial DNA, which 
is also unmethylated at CpG motifs [117], and TLR7 and 9 have been implicated in the 
pathogenesis of autoimmune diseases, such as systemic lupus erythematosus, which is also 
correlated with a high level of Type I Interferon (IFN) [118].  
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Our data suggest the necessity to study the mechanism that leads to increased expression 
of in TLR7/9 in murine and human alveolar macrophages. Performing a microarray analysis on 
RAW 264.7 macrophages exposed to LPS or silica, with or without priming, help to elucidate 
which specific TLR is enhanced by silica alone and the contribution of LPS in the development of 
inflammation.  
Previous studies have also found a correlation between TLR7/9 signaling and macrophage 
metabolic alteration. Wu et al. reported that that TLR7/9 were associated with increased glycolysis 
and lipid metabolism in plasmacytoid dendritic cells [119]. Specifically, TLR7 signaling induces 
early glycolysis and extracellular acidification rate, through HIF-1α-mediated enhanced 
expression [119]. Consequently, it is essential to perform the metabolomic analysis in 
macrophages in the presence of TLR7/9 inhibitor, to study the correlation between TRL7/9 
expression and the metabolic reprogramming of alveolar macrophages.  
Previous studies reported that in contrast to silicosis, BAL, and serum concentrations of 
CCSP are markedly increased in IPF, although most of the studied IPF patients were smokers [37], 
and the serum concentration of CCSP is also grown in other fibrotic lung diseases like 
hypersensitivity pneumonitis and those associated with some connective tissue diseases [37-39]. 
Based on this evidence, we have analyzed samples of lungs explants from healthy control and IPF 
patients, and we found classical fibrotic changes, including honeycomb and fibroblastic foci, 
mainly in the lower lung lobe. The flow sorting of cells from lung tissue instead revealed that 
fibrosis altered the proportion of cell types, but in particular, the club cells and macrophages were 
highly increased in IPF. In sharp contrast, the CCSP expression was reduced in the lung of silica-
exposed subjects, which was associated with caspase activation and increased expression of TNF-
α in silica loaded alveolar macrophages. These preliminary data suggest the necessity to study the 
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mechanism that regulates the different expression of CCSP in silica and IPF. Performing a single-
cell RNA sequencing in these lungs helps to understand the changes in epithelial or macrophages 
hierarchy. Moreover, it would be essential to perform metabolic and respiratory analysis on human 
alveolar macrophages to determine the effects of silica on glycolysis, ETC complexes and TCA 
intermediates, and the correlation to the secretion of pro-inflammatory cytokines.  
Macrophages are the only cells capable of removing silica particles from the lung, and the 
development of chronic inflammation and the progression of interstitial fibrosis is based on their 
survival and ability of clear silica particles.  Therefore, it is possible that improving macrophages 
viability could reduce the burden of silica particles from the lungs of silica-exposed mice. Studies 
on Nitrated derivatives of fatty acids (NO2-FA) have shown that they can modulate nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2)-regulated antioxidant gene expression and NF-κB-dependent 
signaling, inhibiting DNA binding and downstream pro-inflammatory gene expression. 
Specifically, NO2-FAs can induce stabilization of Nrf2 by forming a covalent adduct with 
determinant cysteine residues (Cys273 and 288) of Kelch-like ECH-associated protein (Keap)-1 
in the cytoplasm, and inhibition of the pro-inflammatory transcriptional activity of NF-κB via 
alkylation of essential cysteines of the p65 (Cys 38) and p50 (Cys 62) subunits of NF- κB[120] 
[121], which is fundamental for the resolution of silica-induced injury [10]. In support of the anti-
inflammatory role of NO2-FAs, Ambrozova et al. reported that nitro-oleic acid (OA-NO2) inhibits 
the production of reactive inflammatory mediators (ROS) and pro-inflammatory cytokines (TNF-
α, and IL-1β) through downregulation of MAPKs and NF-κB, in LPS-activated RAW 264.7 and 
BMD macrophages [122]. 
 Based on this evidence, we speculate that electrophilic NO2-FA can block NF-κB 
activation in silica exposed macrophages, decrease the release of pro-inflammatory cytokines IL-
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1β, TNF-α and interferon, improving macrophages survival, and ultimately stimulating the 
resolution of silica-induced pulmonary inflammation and fibrosis, resulting in a possible 
therapeutic intervention on the progression and resolution of lung fibrosis, and the risk of 
mycobacterial infections.  
 97 
Appendix A Microarray Analysis Transcripts 
Appendix Table 1 List of Genes 
Gene bank Symbol Description Gene name 
NM_009652   Akt1   
Thymoma viral proto-
oncogene 1   Akt, PKB, PKB, Akt, PKBalpha 
NM_007497  Atf1  
Activating transcription 
factor 1  - 
NM_009715  Atf2  
Activating transcription 
factor 2  
Atf-2, CRE-BP, Creb2, D130078H02Rik, D18875, 
MGC105211, MGC105222, Tg(Gzma-
Klra1)7Wum, mXBP 
NM_009740  Bcl10  
B-cell 
leukemia/lymphoma 10  
AI132454, BCL-10, C81403, CARMEN, CIPER, 
CLAP, ME10, cE10 
NM_033601  Bcl3  
B-cell 
leukemia/lymphoma 3  AI528691, Bcl-3 
NM_009778  C3  
Complement component 
3  AI255234, ASP, Plp 
NM_130859  Card10  
Caspase recruitment 
domain family, member 
10  AI449026, Bimp1, CARMA3 
NM_172729  Nod1  
Nucleotide-binding 
oligomerization domain 
containing 1  C230079P11, Card4, F830007N14Rik, Nlrc1 
NM_009807  Casp1  Caspase 1  ICE, Il1bc 
NM_009812  Casp8  Caspase 8  Caspase-8, FLICE, MACH, Mch5 
NM_011333  Ccl2  
Chemokine (C-C motif) 
ligand 2  
AI323594, HC11, JE, MCAF, MCP-1, MCP1, 
SMC-CF, Scya2, Sigje 
NM_009805  Cflar  
CASP8 and FADD-like 
apoptosis regulator  
2310024N18Rik, A430105C05Rik, AI646576, 
AU021929, CLARP, Cash, Casper, 
ENSMUSG00000072980, FLAME, Flip, I-
FLICE, MGC103395, MRIT, c-Flip 
NM_007700  Chuk  
Conserved helix-loop-
helix ubiquitous kinase  
AI256658, Chuk1, Fbx24, Fbxo24, IKK-1, IKK-
alpha, IKK1, IKK[a], IKKalpha 
NM_00102543
2  Crebbp  CREB binding protein  AW558298, CBP, CBP, p300, KAT3A, p300, CBP 
NM_009969  Csf2  
Colony stimulating 
factor 2 (granulocyte-
macrophage)  
Csfgm, Gm-CSf, MGC151255, MGC151257, 
MGI-IGM 
NM_009971  Csf3  
Colony stimulating 
factor 3 (granulocyte)  Csfg, G-CSF, MGI-IG 
NM_010336  Lpar1  
Lysophosphatidic acid 
receptor 1  
5031439C20, AI326300, Edg2, Gpcr26, Kdt2, 
MGC29102, lpA1, vzg-1 
NM_007913  Egr1  Early growth response 1  
A530045N19Rik, ETR103, Egr-1, Krox-1, Krox-
24, Krox24, NGF1-A, NGFI-A, NGFIA, TIS8, 
Zenk, Zfp-6, Zif268, egr 
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NM_007922  Elk1  
ELK1, member of ETS 
oncogene family  Elk-1 
NM_010169  F2r  
Coagulation factor II 
(thrombin) receptor  AI482343, Cf2r, MGC28086, Par1, ThrR 
NM_010175  Fadd  
Fas (TNFRSF6)-
associated via death 
domain  Mort1, FADD 
NM_010177  Fasl  
Fas ligand (TNF 
superfamily, member 6)  
APT1LG1, CD178, CD95L, Fas-L, Fas-Ligand, 
Faslg, Tnfsf6, gld 
NM_010234  Fos  
FBJ osteosarcoma 
oncogene  D12Rfj1, c-fos 
NM_010288  Gja1  
Gap junction protein, 
alpha 1  
AU042049, AW546267, Cnx43, Cx43, 
Cx43alpha1, Gja-1, Npm1, connexin43 
NM_008311  Htr2b  
5-hydroxytryptamine 
(serotonin) receptor 2B  5-HT2B, AJ012488, AV377389 
NM_010493  Icam1  
Intercellular adhesion 
molecule 1  CD54, Icam-1, Ly-47, MALA-2, MGC6195 
NM_008337  Ifng  Interferon gamma  IFN-g, IFN-gamma, Ifg 
NM_010546  Ikbkb  
Inhibitor of kappaB 
kinase beta  
AI132552, IKK-2, IKK-beta, IKK2, IKK[b], 
IKKbeta 
NM_019777  Ikbke  
Inhibitor of kappaB 
kinase epsilon  AW558201, IKK-i, IKKepsilon, Ikki 
NM_010547  Ikbkg  
Inhibitor of kappaB 
kinase gamma  
1110037D23Rik, AI848108, AI851264, 
AW124339, IKK[g], NEMO 
NM_010548  Il10  Interleukin 10  CSIF, Il-10 
NM_010554  Il1a  Interleukin 1 alpha  Il-1a 
NM_008361  Il1b  Interleukin 1 beta  IL-1beta, Il-1b 
NM_008362  Il1r1  
Interleukin 1 receptor, 
type I  CD121a, CD121b, IL-iR, Il1r-1, MGC129154 
NM_031168  Il6  Interleukin 6  Il-6 
NM_008363  Irak1  
Interleukin-1 receptor-
associated kinase 1  
AA408924, IRAK, IRAK-1, IRAK1-S, Il1rak, 
Plpk, mPLK 
NM_172161  Irak2  
Interleukin-1 receptor-
associated kinase 2  
6330415L08Rik, AI649099, IRAK-2, 
MGC102586 
NM_008390  Irf1  
Interferon regulatory 
factor 1  AU020929, Irf-1 
NM_010591  Jun  Jun oncogene  AP-1, Junc, c-jun 
NM_010735  Lta  Lymphotoxin A  
LT, LT-[a], LT-alpha, LT[a], LTalpha, Ltx, 
MGC117668, TNF-beta, TNFSF1, Tnfb, Tnfsf1b, 
hlb382 
NM_010736  Ltbr  Lymphotoxin B receptor  
AI256028, CD18, LTbetaR, Ltar, TNF-R-III, 
TNFCR, TNFR-RP, TNFR2-RP, TNFRrp, Tnfbr, 
Tnfrsf3 
NM_011945  Map3k1  
Mitogen-activated 
protein kinase kinase 
kinase 1  MAPKKK1, MEKK1, Mekk 
NM_011952  Mapk3  
Mitogen-activated 
protein kinase 3  
Erk-1, Erk1, Esrk1, Prkm3, p44, p44erk1, 
p44mapk 
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NM_010851  Myd88  
Myeloid differentiation 
primary response gene 
88  - 
XM_904112  Nlrp12  
NLR family, pyrin 
domain containing 12  Nalp12 
NM_008689  Nfkb1  
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 1, 
p105  
NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, 
p50, p105 
NM_019408  Nfkb2  
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 2, 
p49/p100  NF-kappaB2, lyt, p49, p49, p100, p50B, p52 
NM_010907  Nfkbia  
Nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, alpha  AI462015, Nfkbi 
NM_020005  Kat2b  
K(lysine) 
acetyltransferase 2B  A930006P13Rik, AI461839, AW536563, Pcaf 
NM_011163  Eif2ak2  
Eukaryotic translation 
initiation factor 2-alpha 
kinase 2  
2310047A08Rik, 4732414G15Rik, AI467567, 
AI747578, Pkr, Prkr, Tik 
NM_029780  Raf1  
V-raf-leukemia viral 
oncogene 1  
6430402F14Rik, AA990557, BB129353, Craf1, 
D830050J10Rik, MGC102375, Raf-1, c-Raf, v-
Raf 
NM_009044  Rel  
Reticuloendotheliosis 
oncogene  c-Rel 
NM_009045  Rela  
V-rel 
reticuloendotheliosis 
viral oncogene homolog 
A (avian)  p65 
NM_009046  Relb  
Avian 
reticuloendotheliosis 
viral (v-rel) oncogene 
related B  MGC143683, MGC143684 
NM_009068  Ripk1  
Receptor (TNFRSF)-
interacting serine-
threonine kinase 1  D330015H01Rik, RIP, Rinp, Rip1 
NM_138952  Ripk2  
Receptor (TNFRSF)-
interacting serine-
threonine kinase 2  
2210420D18Rik, CARD3, CARDIAK, CCK, 
D4Bwg0615e, RICK, RIP2 
NM_015747  Slc20a1  
Solute carrier family 20, 
member 1  AI607883, Glvr-1, Glvr1 
NM_016769  Smad3  
MAD homolog 3 
(Drosophila)  AU022421, Madh3 
NM_009283  Stat1  
Signal transducer and 
activator of transcription 
1  2010005J02Rik, AA408197 
NM_019786  Tbk1  TANK-binding kinase 1  
1200008B05Rik, AI462036, AW048562, 
MGC150301, MGC150302 
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NM_009370  Tgfbr1  
Transforming growth 
factor, beta receptor I  ALK5, AU017191, Alk-5, TbetaR-I, TbetaRI 
NM_009371  Tgfbr2  
Transforming growth 
factor, beta receptor II  
1110020H15Rik, AU042018, DNIIR, RIIDN, 
TBR-II, TbetaR-II, TbetaRII 
NM_030682  Tlr1  Toll-like receptor 1  - 
NM_011905  Tlr2  Toll-like receptor 2  Ly105 
NM_126166  Tlr3  Toll-like receptor 3  AI957183 
NM_021297  Tlr4  Toll-like receptor 4  Lps, Ly87, Ran, M1, Rasl2-8 
NM_011604  Tlr6  Toll-like receptor 6  - 
NM_133211  Tlr7  Toll-like receptor 7  - 
NM_133212  Tlr8  Toll-like receptor 8  - 
NM_031178  Tlr9  Toll-like receptor 9  - 
NM_013693  Tnf  Tumor necrosis factor  
DIF, MGC151434, TNF-alpha, TNFSF2, 
TNFalpha, Tnfa, Tnfsf1a 
NM_009397  Tnfaip3  
Tumor necrosis factor, 
alpha-induced protein 3  A20, Tnfip3 
NM_020275  
Tnfrsf10
b  
Tumor necrosis factor 
receptor superfamily, 
member 10b  
DR5, KILLER, Killer, Dr5, Ly98, MK, TRAIL-
R2, TRAILR2, TRICK2A, TRICK2B, TRICKB 
NM_011609  Tnfrsf1a  
Tumor necrosis factor 
receptor superfamily, 
member 1a  
CD120a, FPF, TNF-R, TNF-R-I, TNF-R1, TNF-
R55, TNF-alphaR1, TNFAR, TNFR60, TNFRI, 
TNFRp55, TNFalpha-R1, Tnfr-2, Tnfr1, p55, p55-
R 
NM_011610  Tnfrsf1b  
Tumor necrosis factor 
receptor superfamily, 
member 1b  
CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-
alphaR2, TNFBR, TNFR80, TNFRII, TNFalpha-
R2, Tnfr-1, Tnfr2, p75 
NM_011611  Cd40  CD40 antigen  
AI326936, Bp50, GP39, HIGM1, IGM, IMD3, T-
BAM, TRAP, Tnfrsf5, p50 
NM_00103312
6  Cd27  CD27 antigen  S152, Tnfrsf7, Tp55 
NM_009425  Tnfsf10  
Tumor necrosis factor 
(ligand) superfamily, 
member 10  
A330042I21Rik, AI448571, APO-2L, Ly81, TL2, 
Trail 
NM_019418  Tnfsf14  
Tumor necrosis factor 
(ligand) superfamily, 
member 14  HVEM-L, HVEML, LIGHT, LTg, Ly113 
NM_023764  Tollip  Toll interacting protein  4930403G24Rik, 4931428G15Rik 
NM_00103316
1  Tradd  
TNFRSF1A-associated 
via death domain  9130005N23Rik, AA930854 
NM_009422  Traf2  
Tnf receptor-associated 
factor 2  AI325259 
NM_011632  Traf3  
Tnf receptor-associated 
factor 3  
AI528849, CAP-1, CD40bp, CRAF1, LAP1, T-
BAM, amn 
NM_009539  Zap70  
Zeta-chain (TCR) 
associated protein kinase  70kDa, AI327364, Srk, TZK, ZAP-70, mrtle, mur 
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Appendix B Metabolic Analysis 
 
Appendix Figure 1 Schematic summarizing the key glycolysis and TCA metabolites and aminoacids 
significantly altered in RAW cells after LPS (blue) or Silica (red) exposure 
 
Raw cells were exposed to vehicle, LPS (10 ng/ml) or silica (50 μg/cm2) for 6 hours. 
Statistical analysis was performed on RAW cells from 6 samples for each condition. The graph 
shows metabolites significantly differentially regulated by LPS or Silica. Metabolites with p-value 
<0.05 and fold-change >10% were deemed to be statistically significant.  
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